Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3035999	li-laktaat	mmol/l (mmol/l)	2903	3517	0.28%
3035999	li-laktaat	— (—)	280	301	100.00%	Distribution not available
3035999	li-laktteh	mmol/l (mmol/l)	192	296	0.00%
3035999	li-laktteh	— (—)	45	65	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hydrocephalus

252

144

18.94

313.39

2.3

1.2

2.36

2.06

mmol/l

2.25

240

134

Other symptoms and signs involving cognitive functions and awareness

602

930

6.02

307.65

1.2

1.3

2.12

2.21

mmol/l

0.67

566

855

Other neurological diseases

890

1550

4.59

307.65

1.5

1.2

2.09

2.15

mmol/l

0.54

828

1431

Epilepsy

512

671

7.81

307.65

1.5

1.3

2.23

2.13

mmol/l

0.71

477

625

General symptoms and signs

1100

1238

4.50

307.65

1.3

1.2

2.00

2.07

mmol/l

0.69

1029

1153

Neurological diseases

903

592

7.76

307.65

1.3

1.1

1.89

2.09

mmol/l

2.16

846

547

Headache

992

1130

7.16

307.65

1.3

1.2

1.89

2.04

mmol/l

3.09

917

1050

Symptoms and signs involving the nervous and musculoskeletal systems

822

1603

5.24

307.65

1.3

1.89

2.16

mmol/l

7.52

768

1490

Other degenerative diseases of the nervous system

411

185

17.02

307.65

1.2

1.1

1.80

2.05

mmol/l

2.66

382

166

Inflammatory diseases of the central nervous system

306

213

15.63

307.65

1.9

1.2

3.05

1.95

mmol/l

9.17

295

203

Symptoms and signs involving cognition, perception, emotional state and behaviour

1066

1939

3.80

303.86

1.2

1.3

2.00

2.11

mmol/l

1.67

993

1797

Other symptoms and signs involving the nervous and musculoskeletal systems

591

1139

5.30

288.67

1.3

1.88

2.10

mmol/l

4.33

559

1062

Fever of other and unknown origin

584

1009

5.22

270.95

1.3

1.2

2.15

2.05

mmol/l

0.74

540

942

Convulsions, not elsewhere classified

351

422

8.41

265.66

1.4

1.2

2.08

1.94

mmol/l

1.14

317

399

Intracranial trauma

452

432

7.43

264.98

1.4

1.1

2.08

1.94

mmol/l

0.86

408

399

Neurological diseases, wide definition

360

118

15.55

259.86

1.3

1.1

1.85

mmol/l

0.00

337

109

Concussion

386

424

7.51

245.51

1.3

1.1

2.04

1.95

mmol/l

0.43

347

391

Focal epilepsy

374

557

6.93

238.91

1.4

1.2

2.22

1.99

mmol/l

2.33

347

517

Demyelinating diseases of the central nervous system

250

230

11.57

236.33

1.1

1.3

1.67

2.00

mmol/l

4.10

235

211

Focal epilepsy, strict definition

354

513

7.13

232.11

1.4

1.2

2.19

2.01

mmol/l

1.83

329

476

Viral infections of the central nervous system

229

193

12.67

229.34

1.4

1.3

2.18

1.96

mmol/l

2.09

215

181

Viral infections of the central nervous system

221

181

13.08

225.44

1.4

1.3

2.19

1.97

mmol/l

2.08

209

170

Cerebrovascular diseases

743

1372

3.86

218.89

1.5

1.2

2.28

2.14

mmol/l

1.61

685

1275

Focal epilepsy, mode (most common among epilepsy diagnosis)

333

489

7.04

215.69

1.4

1.2

2.26

2.01

mmol/l

2.27

310

453

Cerebrovascular diseases (FINNGEN)

455

571

5.76

212.17

1.6

1.1

2.25

1.92

mmol/l

5.66

419

538

Malaise and fatigue

491

793

5.05

211.56

1.3

1.2

2.01

2.10

mmol/l

0.77

455

739

Abnormal findings on diagnostic imaging of central nervous system

177

117

16.53

204.83

1.3

1.4

1.88

1.97

mmol/l

0.45

163

109

MS-disease / Multiple Sclerosis

205

174

12.53

204.26

1.1

1.4

1.67

1.89

mmol/l

4.30

190

162

Episodal and paroxysmal disorders

993

1577

3.23

202.93

1.3

1.2

1.92

2.11

mmol/l

3.78

923

1462

Meningitis

171

116

16.02

194.95

2.1

1.2

3.51

1.91

mmol/l

7.30

165

110

Condition for Implicit Sepsis (Organ dysfunction codes)

818

1777

3.28

191.58

1.2

1.3

2.13

2.04

mmol/l

0.75

762

1647

Implicit Sepsis

736

1620

3.47

191.07

1.2

1.3

2.16

2.05

mmol/l

1.12

683

1506

Stroke, including SAH

612

1175

3.83

180.68

1.5

1.2

2.35

2.17

mmol/l

1.94

559

1091

STROKE

590

1056

3.85

171.60

1.5

1.2

2.24

2.05

mmol/l

2.68

545

987

Migraine

503

1064

3.88

157.19

1.2

1.3

1.80

2.00

mmol/l

4.22

471

992

Visual disturbances and blindness

539

1565

3.49

153.00

1.3

1.94

2.13

mmol/l

2.99

485

1467

Bacterial infection, other or unspecified

520

1255

3.64

151.51

1.3

2.34

2.07

mmol/l

2.77

482

1161

Other demyelinating diseases of the central nervous system

132

15.79

149.25

1.2

1.5

1.68

1.91

mmol/l

2.30

126

Postprocedural disorders of nervous system

166

10.49

147.81

1.3

1.2

1.71

2.01

mmol/l

1.64

155

156

Bacterial infection, other or unspecified

547

1354

3.46

146.46

1.3

2.32

2.06

mmol/l

2.97

508

1252

Spirochaetal infections, other/unspecified

184

215

8.98

145.76

1.2

1.3

1.89

2.12

mmol/l

1.91

167

205

Cerebral cysts

143

117

12.92

145.69

1.3

1.2

1.74

1.99

mmol/l

2.31

134

109

Visual disturbances

498

1459

3.46

139.60

1.3

1.90

2.09

mmol/l

3.46

451

1369

Dizziness and giddiness

626

1613

3.10

139.05

1.3

1.94

2.14

mmol/l

3.56

579

1492

Implicit bacterial Sepsis

397

869

4.11

137.61

1.3

2.32

2.08

mmol/l

1.76

361

805

Stroke, excluding SAH

530

1129

3.47

136.48

1.4

1.3

2.26

2.21

mmol/l

0.32

485

1044

Bacterial Sepsis

429

978

3.80

132.23

1.3

2.42

2.08

mmol/l

2.98

391

906

Other headache syndromes

386

1009

3.87

127.97

1.2

1.3

1.83

2.09

mmol/l

6.38

360

941

Benign intracranial hypertension

65.09

125.33

1.1

1.4

1.56

1.81

mmol/l

0.69

Implicit viral Sepsis

247

464

5.44

124.52

1.3

2.27

1.99

mmol/l

1.39

228

431

Viral Sepsis

247

464

5.44

124.52

1.3

2.27

1.99

mmol/l

1.39

228

431

Infections, IBD-co-morbidities

142

13.72

124.31

1.3

1.1

2.17

1.92

mmol/l

0.99

132

Abnormalities of gait and mobility

182

258

7.28

121.99

1.3

1.2

1.91

2.14

mmol/l

1.77

165

243

Certain infectious and parasitic diseases

760

1382

2.77

120.71

1.3

1.2

2.05

1.96

mmol/l

1.17

718

1275

Sequelae of cerebrovascular disease

327

683

4.19

115.46

1.6

1.2

2.24

2.23

mmol/l

0.05

303

638

Polyneuropathies and other disorders of the peripheral nervous system

262

558

4.80

114.32

1.2

1.3

2.02

2.14

mmol/l

1.08

245

526

Delirium, not induced by alcohol and other psychoactive substances

161

227

7.27

108.06

1.3

1.2

2.09

2.13

mmol/l

0.21

150

208

Nontraumatic intracranial haemmorrhage

212

399

5.41

106.59

2.0

1.2

2.77

2.14

mmol/l

5.27

188

373

Ischaemic Stroke, excluding all haemorrhages

461

1092

3.17

104.42

1.3

2.18

2.23

mmol/l

0.31

429

1008

Other bacterial diseases

750

2058

2.47

104.13

1.3

2.32

2.01

mmol/l

5.20

693

1911

Disturbances of skin sensation

322

864

3.79

103.38

1.2

1.3

1.70

2.00

mmol/l

11.45

297

809

Pain, not elsewhere classified

236

504

4.74

102.35

1.3

1.91

2.01

mmol/l

0.71

210

474

Organic, including symptomatic, mental disorders

420

910

3.32

100.80

1.2

1.3

2.08

2.28

mmol/l

2.16

386

839

Disorders of optic nerve and visual pathways

164

263

6.45

98.00

1.3

1.72

1.98

mmol/l

2.90

148

246

Aneurysms, operations, SAH

191

358

5.45

96.66

2.1

1.3

2.64

2.13

mmol/l

3.81

175

338

Speech disturbances, not elsewhere classified

146

213

7.09

95.47

1.4

1.2

2.13

2.02

mmol/l

0.49

137

200

Anaemias

222

270

5.44

95.25

1.2

1.1

2.07

1.70

mmol/l

4.49

205

255

Autoimmune diseases excluding thyroid diseases

819

1934

2.33

94.59

1.2

1.3

2.00

2.08

mmol/l

0.82

771

1791

Medical observation and evaluation for suspected diseases and conditions

515

891

2.98

93.24

1.3

1.2

1.97

2.11

mmol/l

1.37

480

829

Autoimmune diseases excluding thyroid diseases, strict definition

794

1870

2.34

93.09

1.2

1.3

1.99

2.08

mmol/l

0.76

748

1729

Other and unspecified polyneuropathies, also in other diseases

221

486

4.64

92.82

1.2

1.3

2.01

2.13

mmol/l

1.03

206

457

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

245

229

5.40

92.41

1.4

1.2

2.01

2.19

mmol/l

0.53

233

207

Syncope and collapse

316

754

3.62

91.58

1.2

2.09

2.10

mmol/l

0.04

293

704

Autoimmune diseases related-to ILD

682

2507

2.34

89.74

1.2

1.3

1.94

2.09

mmol/l

2.59

633

2322

Malignant neoplasm of brain, including Hilmo

105

112

9.82

89.25

1.9

1.3

2.52

2.01

mmol/l

2.34

107

Subarachnoid haemorrhage

137

205

6.86

87.35

2.4

1.3

2.91

2.16

mmol/l

4.36

123

194

Hypo-osmolality and hyponatraemia

187

382

4.96

85.08

1.5

1.3

2.41

2.14

mmol/l

0.79

174

355

Other disorders of fluid, electrolyte and acid-base balance

280

738

3.66

84.73

1.4

1.3

2.41

2.19

mmol/l

0.88

262

684

Persons encountering health services in other circumstances

366

1217

3.02

82.55

1.3

2.10

2.01

mmol/l

0.37

341

1125

Other bacterial diseases

760

2195

2.21

81.52

1.3

1.2

2.24

1.99

mmol/l

4.12

706

2031

Other antidepressants

757

1722

2.27

81.06

1.2

2.05

2.11

mmol/l

0.56

708

1595

659

1705

2.35

80.73

1.3

1.2

2.20

2.00

mmol/l

3.40

612

1583

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

659

1705

2.35

80.73

1.3

1.2

2.20

2.00

mmol/l

3.40

612

1583

Migraine without aura

202

464

4.42

80.20

1.2

1.3

1.71

1.93

mmol/l

3.50

188

438

General examination and investigation of persons without complaint and reported diagnosis

479

890

2.83

80.20

1.3

1.2

2.03

2.11

mmol/l

0.66

450

828

Anxiety disorders, excluding more controls

612

1667

2.40

79.98

1.3

1.2

2.02

2.06

mmol/l

0.31

563

1557

Mood disorders, excluding more controls

678

1774

2.30

78.19

1.3

1.2

2.04

2.08

mmol/l

0.35

626

1655

Traumatic subdural haemorrhage

9.83

76.38

1.5

1.1

2.44

2.13

mmol/l

0.82

Alzheimer disease, excluding more controls

109

9.95

76.06

1.2

2.05

2.19

mmol/l

0.40

Diplopia

164

335

5.01

75.44

1.2

1.3

1.91

2.09

mmol/l

1.62

149

318

Disorders of thyroid, IBD co-morbidities

107

9.36

74.61

1.5

1.1

2.20

1.89

mmol/l

1.44

100

Nausea and vomiting

253

705

3.56

74.12

1.3

2.07

2.04

mmol/l

0.19

239

652

Migraine with aura

219

576

3.85

72.40

1.2

1.3

1.77

1.97

mmol/l

3.42

205

544

Influenza and pneumonia

782

2403

2.08

72.30

1.3

1.2

2.16

1.99

mmol/l

2.78

726

2232

Anxiety disorders

684

2213

2.17

71.65

1.2

1.3

1.98

2.06

mmol/l

0.78

631

2059

Pneumonia, organism unspecified

673

2179

2.18

71.49

1.3

2.21

2.02

mmol/l

2.86

626

2026

Opioids

724

1738

2.18

70.98

1.2

1.3

2.00

2.04

mmol/l

0.35

668

1620

Neurotic, stress-related and somatoform disorders

677

2204

2.16

70.61

1.2

1.3

1.97

2.06

mmol/l

0.97

625

2052

Complications of medical and surgical care

553

2231

2.30

70.56

1.6

1.2

2.18

2.07

mmol/l

1.00

520

2062

Other soft tissue disorders, not elsewhere classified

711

1945

2.16

70.41

1.2

1.3

1.92

2.10

mmol/l

3.73

664

1803

Symptoms and signs involving the skin and subcutaneous tissue

538

2307

2.30

69.73

1.2

1.3

1.83

2.13

mmol/l

11.69

500

2143

ILD medications

821

2189

2.04

69.61

1.2

1.3

2.02

2.05

mmol/l

0.18

756

2034

Explicit Sepsis

329

1057

2.93

69.47

1.4

1.3

2.50

2.04

mmol/l

3.91

304

976

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

713

2361

2.09

68.43

1.3

2.19

2.04

mmol/l

1.80

664

2195

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

483

1810

2.41

68.23

1.3

2.03

2.17

mmol/l

1.71

450

1674

Used for control exclusion in common control thyroid runs

745

1784

2.12

68.11

1.3

1.95

2.08

mmol/l

2.00

690

1652

Dorsalgia

723

1833

2.12

67.47

1.2

1.3

1.95

2.11

mmol/l

2.98

666

1704

Low back pain

561

1778

2.28

66.89

1.2

1.3

1.93

2.13

mmol/l

3.77

516

1654

Benzodiazepine use

734

2479

2.05

66.53

1.3

1.2

1.97

2.10

mmol/l

2.74

682

2293

Any mental disorder

751

1806

2.09

66.25

1.3

1.2

2.10

2.08

mmol/l

0.12

689

1685

Persons encountering health services for specific procedures and health care

780

2329

2.02

65.69

1.4

1.2

2.11

1.99

mmol/l

1.82

708

2180

Myalgia

234

688

3.45

65.62

1.2

1.4

1.87

2.05

mmol/l

1.94

216

641

Nerve, nerve root and plexus disorders

755

2293

2.03

64.70

1.2

1.3

2.02

2.11

mmol/l

1.06

707

2122

Other septicaemia

287

921

3.03

64.52

1.4

1.3

2.32

2.08

mmol/l

2.34

265

854

All pneumoniae

730

2417

2.03

64.02

1.3

1.2

2.19

2.01

mmol/l

3.03

674

2248

First line medication for Crohn's disease

787

2127

2.01

63.81

1.3

1.2

2.12

2.00

mmol/l

1.28

725

1977

Mood [affective] disorders

738

2380

2.02

63.51

1.2

1.3

2.01

2.08

mmol/l

0.80

678

2211

Mood disorders

739

2382

2.02

63.38

1.2

1.3

2.01

2.08

mmol/l

0.83

679

2213

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

712

2397

2.04

63.36

1.3

1.2

2.20

2.03

mmol/l

2.62

657

2229

Pneumonias (Asthma/COPD co-morbidities)

722

2406

2.03

63.07

1.3

1.2

2.18

2.00

mmol/l

2.94

668

2237

Oedema, not elsewhere classified

205

561

3.64

62.47

1.3

2.08

2.11

mmol/l

0.09

194

523

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

454

1917

2.36

62.43

1.6

1.2

2.14

2.09

mmol/l

0.38

428

1767

Septicaemia

311

1033

2.84

62.10

1.4

1.3

2.53

2.08

mmol/l

3.44

288

956

Intracranial injury

444

1780

2.38

61.82

1.4

1.3

2.01

2.08

mmol/l

0.62

398

1652

ILD medications: prednisolone, methylprednisolone, prednisone

764

2150

2.00

61.52

1.2

1.3

2.10

2.06

mmol/l

0.30

703

1996

Spirochaetal infections, other/unspecified

269

897

3.04

61.27

1.2

1.3

1.93

2.09

mmol/l

1.96

245

841

Other dorsopathies, not elsewhere classified

717

1839

2.05

60.87

1.2

1.3

1.91

2.11

mmol/l

3.97

663

1710

Other spirochaetal diseases

269

906

3.01

60.21

1.2

1.3

1.93

2.08

mmol/l

1.89

245

850

Lyme disease

265

886

3.03

60.09

1.2

1.3

1.93

2.09

mmol/l

1.90

241

832

Autoimmune diseases

761

1948

2.00

59.68

1.2

1.3

1.98

2.08

mmol/l

1.42

706

1804

Parkinson's disease, excluding more controls

8.93

59.66

1.2

1.94

2.14

mmol/l

0.71

Other spirochaetal diseases

266

895

3.01

59.65

1.2

1.3

1.93

2.09

mmol/l

1.82

242

840

Cerebral palsy and other paralytic syndromes

136

291

4.78

59.27

1.9

1.3

2.01

mmol/l

0.00

127

274

ILD medications: immunosuppressive drugs

472

1946

2.27

58.87

1.2

1.3

2.09

2.07

mmol/l

0.09

443

1813

Depression

683

2315

2.01

58.62

1.2

1.3

2.01

2.07

mmol/l

0.58

621

2154

Parasetamol

522

1151

2.31

58.51

1.3

1.2

1.96

2.00

mmol/l

0.31

486

1072

Complications of surgical and medical care, not elsewhere classified

696

2406

1.99

58.38

1.5

1.2

2.13

2.07

mmol/l

0.63

657

2221

Other special examinations and investigations of persons without complaint or reported diagnosis

438

891

2.50

58.09

1.3

1.2

2.00

2.11

mmol/l

0.89

407

829

Psychiatric diseases

654

1574

2.09

57.71

1.3

2.05

2.10

mmol/l

0.41

608

1466

Depression medications

223

299

3.78

57.04

1.3

1.1

1.88

1.69

mmol/l

1.80

209

283

Other disorders of optic [2nd] nerve and visual pathways

162

6.25

56.95

1.4

1.75

1.92

mmol/l

1.60

153

Persons encountering health services in other circumstances, wide

789

2132

1.91

55.19

1.3

1.2

2.10

2.06

mmol/l

0.26

739

1966

COPD/asthma related infections

683

1706

2.01

54.72

1.3

1.2

2.10

2.00

mmol/l

1.19

636

1584

COPD/asthma/ILD related infections

683

1706

2.01

54.72

1.3

1.2

2.10

2.00

mmol/l

1.19

636

1584

Tramadol

540

1546

2.16

54.53

1.2

1.3

2.00

2.07

mmol/l

0.73

498

1437

Parkinson's disease, strict definition, excluding more controls

8.96

53.81

1.2

1.96

2.17

mmol/l

0.70

Bleeding

558

1912

2.09

53.65

1.6

1.2

2.40

2.08

mmol/l

4.82

504

1782

Bell's palsy

132

300

4.49

53.41

1.2

1.3

2.05

2.02

mmol/l

0.11

127

277

Oral corticosteroids

736

2295

1.91

53.22

1.3

2.11

2.06

mmol/l

0.33

679

2131

Diseases of the eye and adnexa

569

1351

2.12

52.08

1.3

1.2

1.92

2.06

mmol/l

1.55

529

1265

Pain in joint

378

988

2.45

51.68

1.2

1.91

2.21

mmol/l

3.47

346

910

Other anxiety disorders

368

1338

2.40

51.65

1.2

1.3

1.83

1.92

mmol/l

1.06

340

1252

Pain (limb, back, neck, head abdominally)

468

1029

2.29

51.39

1.3

1.2

1.95

2.20

mmol/l

3.20

441

946

Injuries to the head

760

2522

1.86

51.12

1.3

1.2

2.02

2.06

mmol/l

0.43

702

2341

Substance abuse, excluding more controls

379

1382

2.35

50.72

1.2

1.3

2.17

2.07

mmol/l

0.75

351

1295

Cardiovascular diseases (excluding rheumatic etc)

481

1259

2.21

50.62

1.3

1.2

1.99

1.80

mmol/l

3.12

451

1171

Renal tubulo-interstitial diseases

590

2224

1.99

50.12

1.3

1.2

2.21

2.04

mmol/l

2.21

547

2068

Persons with potential health hazards related to communicable diseases

323

1309

2.47

49.41

1.2

1.3

1.86

1.89

mmol/l

0.22

310

1220

Hypothyroidism (congenital or acquired)

186

284

3.73

49.11

1.2

1.1

1.89

1.69

mmol/l

2.04

171

269

All kidney diseases

672

2434

1.90

49.01

1.3

1.2

2.14

2.02

mmol/l

1.60

625

2259

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

406

1840

2.22

48.82

1.7

1.2

2.14

2.11

mmol/l

0.20

383

1695

Metabolic disorders

628

1971

1.95

48.75

1.3

1.2

2.17

2.06

mmol/l

0.88

586

1821

Any gastric operation

536

1279

2.11

48.67

1.4

1.2

1.98

1.99

mmol/l

0.02

500

1188

GASTRO-related operations

536

1279

2.11

48.67

1.4

1.2

1.98

1.99

mmol/l

0.02

500

1188

Benign neoplasm of meninges

111

239

4.74

48.10

1.5

1.3

2.48

2.11

mmol/l

1.23

223

Dementia, including avohilmo

295

771

2.65

48.05

1.2

2.08

2.29

mmol/l

1.70

272

709

Abnormal involuntary movements

126

300

4.27

48.01

1.5

1.2

1.88

2.11

mmol/l

1.91

116

282

Provisional assignment of new diseases of uncertain etiology

388

1743

2.24

47.65

1.3

2.05

2.03

mmol/l

0.10

364

1614

Anxiety (asthma-related co-morbidities)

439

1574

2.17

47.58

1.2

1.3

1.87

1.98

mmol/l

1.40

404

1476

Paralytic strabismus

156

5.79

47.57

1.5

1.2

1.91

2.00

mmol/l

0.54

147

Symptoms and signs involving speech and voice

257

960

2.70

47.52

1.3

2.09

2.06

mmol/l

0.15

242

892

Codes for special purposes

388

1748

2.23

47.32

1.3

2.05

2.02

mmol/l

0.10

364

1618

Migraine without aura and triptan purchases

167

491

3.45

47.04

1.2

1.3

1.69

1.94

mmol/l

4.43

155

463

Dementia

271

686

2.74

47.00

1.2

2.08

2.32

mmol/l

1.72

250

629

Lower back pain or/and sciatica

709

2524

1.84

46.96

1.2

1.3

1.92

2.11

mmol/l

4.96

652

2343

Covid-19 confirmed case

279

1092

2.58

46.92

1.4

1.3

2.13

2.04

mmol/l

0.42

260

1013

Hypothyroidism, levothyroxine purchases

182

284

3.65

46.76

1.2

1.1

1.90

1.69

mmol/l

2.18

169

269

Hypothyroidism and >3 levothyroxin purchases

182

284

3.65

46.76

1.2

1.1

1.90

1.69

mmol/l

2.18

169

269

Inflammatory bowel disease treatment related agents

769

2383

1.81

46.67

1.3

2.09

2.05

mmol/l

0.31

711

2212

Other reaction to severe stress, and adjustment disorders

293

1181

2.50

46.34

1.3

2.07

1.94

mmol/l

0.79

267

1101

Cardiovascular diseases

448

1097

2.21

46.22

1.3

1.2

1.95

1.79

mmol/l

2.25

421

1023

Pain in limb

555

1880

1.99

46.09

1.3

1.96

2.11

mmol/l

2.37

515

1744

Hard cardiovascular diseases

541

1603

2.02

46.05

1.4

1.2

2.18

2.14

mmol/l

0.29

501

1494

Symptoms and signs involving the urinary system

507

1915

2.03

45.93

1.4

1.3

2.16

2.12

mmol/l

0.25

472

1773

Dorsopathies

682

1849

1.88

45.47

1.2

1.3

1.90

2.11

mmol/l

4.74

635

1720

Contact with and exposure to communicable diseases

273

1070

2.57

45.38

1.2

1.3

1.83

1.87

mmol/l

0.31

261

998

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

217

757

2.88

45.29

1.4

1.3

1.99

1.90

mmol/l

0.73

196

710

Persons encountering health services for other counselling and medical advice, not elsewhere classified

714

2128

1.83

44.48

1.2

2.09

2.06

mmol/l

0.20

671

1962

Codeine

602

1704

1.93

43.84

1.2

1.3

2.03

2.05

mmol/l

0.09

547

1588

Other disorders of urethra and urinary system

469

1655

2.06

43.67

1.4

1.2

2.16

2.08

mmol/l

0.52

434

1532

All anxiety disorders

446

1705

2.08

43.56

1.2

1.3

1.87

2.00

mmol/l

1.82

410

1592

Continuous positive airway pressure

148

345

3.65

43.51

1.2

2.12

1.95

mmol/l

0.96

139

332

Oxycodone

262

928

2.57

43.11

1.4

1.3

2.23

2.17

mmol/l

0.35

245

871

Invasive ventilation

190

5.02

43.00

1.3

1.2

2.79

2.00

mmol/l

2.69

181

Benign neoplasm: Cerebral meninges

100

217

4.71

42.97

1.3

2.47

2.13

mmol/l

0.93

203

Any reimbursement code in KELA

408

917

2.24

42.82

1.3

1.2

1.96

1.89

mmol/l

0.55

382

856

Depression or dysthymia

396

982

2.24

42.56

1.3

1.2

2.00

2.14

mmol/l

1.56

364

913

Disorders of ocular muscles, binocular movement, accommodation and refraction

349

1562

2.23

42.54

1.4

1.2

1.94

1.98

mmol/l

0.32

319

1465

Systemic connective tissue disorders

258

1026

2.54

42.06

1.2

1.3

2.09

2.04

mmol/l

0.27

235

949

Other pulmonary diagnosis

496

1217

2.05

41.90

1.4

1.2

2.01

2.06

mmol/l

0.39

462

1131

726

2100

1.79

41.83

1.2

1.3

2.08

2.07

mmol/l

0.06

677

1946

Migraine with aura and triptan purchases

154

465

3.36

41.66

1.2

1.3

1.75

1.94

mmol/l

2.34

143

436

Acute upper respiratory infections of multiple and unspecified sites

502

1903

1.96

41.49

1.3

1.89

2.03

mmol/l

2.64

464

1768

Acute sinusitis

363

1558

2.17

40.89

1.2

1.3

2.14

2.00

mmol/l

0.97

334

1455

Selective serotonin reuptake inhibitors

617

1727

1.87

40.87

1.3

1.2

1.99

2.11

mmol/l

1.59

575

1600

Visual field defects

187

4.91

40.75

1.6

1.3

2.23

2.04

mmol/l

0.48

178

Intracerebral haemorrhage

104

243

4.34

40.63

2.1

1.2

2.74

2.14

mmol/l

2.25

228

Abnormalities of breathing

592

1840

1.88

40.57

1.3

1.99

2.07

mmol/l

0.84

548

1710

Subjective visual disturbances

200

713

2.84

40.56

1.2

1.3

1.77

2.07

mmol/l

7.70

179

670

Cerebral aneurysm, nonruptured

177

5.01

40.37

1.8

1.3

2.24

2.17

mmol/l

0.20

167

Care involving use of rehabilitation procedures

419

1898

2.04

40.18

1.4

1.2

2.02

2.03

mmol/l

0.05

375

1775

Strabismus

223

843

2.67

40.17

1.4

1.3

1.90

1.96

mmol/l

0.46

202

793

Any death

396

1344

2.12

40.03

1.4

1.3

2.62

2.11

mmol/l

6.05

365

1253

Excluding asthma or asthma-COPD overlap

489

1217

2.02

39.83

1.4

1.2

2.00

2.06

mmol/l

0.47

456

1131

COPD differential diagnosis

488

1216

2.02

39.62

1.4

1.2

1.99

2.06

mmol/l

0.61

455

1131

ILD differential diagnosis

488

1216

2.02

39.61

1.4

1.2

1.99

2.06

mmol/l

0.61

455

1131

Any dementia, excluding more controls

217

537

2.80

39.37

1.2

2.03

2.29

mmol/l

2.56

197

496

Acute upper respiratory infections

658

2274

1.79

39.32

1.2

1.3

2.07

2.08

mmol/l

0.11

609

2109

Symptoms and signs involving the circulatory and respiratory systems

664

1844

1.81

39.26

1.3

1.94

2.07

mmol/l

1.93

616

1713

Primary_lymphoid and hematopoietic malignant neoplasms

181

624

2.93

39.06

1.4

1.2

2.34

2.12

mmol/l

0.79

171

587

Fitting and adjustment of other devices

235

832

2.57

38.60

1.3

1.2

2.37

2.13

mmol/l

1.30

213

775

Bronchitis

689

2486

1.75

38.55

1.2

1.3

1.97

2.08

mmol/l

1.62

642

2299

Persons encountering health services for examination and investigation

386

891

2.18

38.16

1.3

1.2

2.02

2.11

mmol/l

0.70

360

829

Extrapyramidal and movement disorders

257

1068

2.43

38.16

1.2

1.3

1.98

2.16

mmol/l

2.17

238

990

Liquid cancers, helper endpoint

258

926

2.45

38.03

1.4

1.3

2.35

2.14

mmol/l

1.04

242

863

Acute tubulo-interstitial nephritis

413

1776

2.02

37.95

1.4

1.2

2.23

2.06

mmol/l

1.46

383

1651

Other and unspecified anaemias

272

1105

2.36

37.75

1.3

2.38

2.14

mmol/l

1.29

249

1027

Other anaemias

274

1114

2.35

37.72

1.3

2.37

2.13

mmol/l

1.25

251

1034

Non-invasive ventilation

170

509

3.01

37.49

1.7

1.2

2.32

1.96

mmol/l

2.46

151

484

Aplastic and other anaemias

292

1204

2.28

37.03

1.3

2.35

2.13

mmol/l

1.16

267

1115

Symptoms and signs involving the digestive system and abdomen

629

1751

1.81

36.96

1.3

1.2

2.01

2.10

mmol/l

0.87

591

1613

Pain in throat and chest

544

1759

1.87

36.92

1.2

1.3

1.95

2.10

mmol/l

2.12

494

1633

Intestinal infectious diseases

613

2641

1.77

36.78

1.3

1.2

1.97

2.07

mmol/l

1.57

563

2452

Exclusions for E4_PCOS_BROAD

159

530

3.04

36.47

1.3

2.10

1.99

mmol/l

0.54

143

493

Fall on same level

739

2375

1.71

36.43

1.3

2.05

2.04

mmol/l

0.08

692

2200

Disorders of other endocrine glands

309

1392

2.20

36.41

1.2

1.3

2.01

1.98

mmol/l

0.22

289

1295

Other diseases of urinary system

631

2001

1.78

36.30

1.3

1.2

2.10

2.05

mmol/l

0.45

591

1856

Diarrhoea and gastroenteritis of presumed infectious origin

467

2252

1.88

35.06

1.3

1.2

1.97

2.05

mmol/l

0.90

425

2087

Soft tissue disorders

661

1965

1.74

34.45

1.2

1.3

1.92

2.10

mmol/l

3.49

617

1821

Complications of procedures, not elsewhere classified

505

2302

1.82

34.13

1.4

1.2

2.11

2.08

mmol/l

0.24

475

2124

Recurrent or chronic depression

246

718

2.42

33.86

1.2

1.93

2.03

mmol/l

0.70

231

673

Brain meningioma, including Hilmo

113

5.72

33.73

1.5

1.2

2.65

2.16

mmol/l

1.02

108

Diseases of the myoneural junction and muscle

111

312

3.61

33.67

1.3

2.17

2.08

mmol/l

0.32

100

296

Personality disorders, excluding more controls

185

699

2.67

33.58

1.2

1.3

1.90

mmol/l

0.05

162

658

Viral infections characterized by skin and mucous membrane lesions

291

1350

2.17

33.30

1.3

2.20

2.01

mmol/l

0.98

279

1257

Brain meningioma

111

5.74

33.27

1.5

1.2

2.65

2.10

mmol/l

1.19

106

Diseases of oesophagus, stomach and duodenum

660

2338

1.69

32.56

1.3

2.02

2.10

mmol/l

1.00

606

2170

Other/unspecified dorsalgia

243

1049

2.31

32.46

1.2

1.3

1.98

2.12

mmol/l

0.86

223

983

Exposure to unspecified factor

631

2687

1.70

32.44

1.3

2.04

2.06

mmol/l

0.08

578

2498

Codeine or tramadol medication

713

2349

1.67

32.44

1.2

1.3

2.08

2.07

mmol/l

0.05

648

2187

Gastro-oesophageal reflux disease

427

1963

1.89

32.36

1.3

2.02

2.15

mmol/l

1.27

391

1826

Any dementia

226

648

2.44

31.46

1.2

2.03

2.30

mmol/l

3.10

206

593

Spondylopathies

460

1481

1.86

31.22

1.4

1.3

2.14

2.20

mmol/l

0.33

425

1378

Substance abuse

379

1858

1.93

31.13

1.2

1.3

2.17

2.06

mmol/l

0.82

351

1735

Alzheimer’s disease (Late onset), excluding more controls

6.49

30.76

1.2

1.1

2.14

2.13

mmol/l

0.02

Pneumonitis due to solids and liquids

176

4.39

30.19

1.8

1.2

2.42

2.07

mmol/l

1.02

162

Diseases of the ear and mastoid process

718

2208

1.64

30.02

1.3

1.93

2.06

mmol/l

2.41

666

2048

Mental and behavioural disorders due to psychoactive substance use

384

1891

1.89

29.78

1.2

1.3

2.17

2.06

mmol/l

0.81

356

1763

Enlarged lymph nodes

280

3.57

29.72

1.2

1.3

2.37

2.04

mmol/l

0.67

266

Schizophrenia or delusion, excluding more controls

196

800

2.44

29.67

1.2

1.3

2.13

1.98

mmol/l

0.68

177

754

Diagnoses used for exclusion with ILD

178

704

2.55

29.55

1.6

1.2

2.30

2.10

mmol/l

1.01

169

664

Asthma, unspecified (mode), excluding more controls

296

1061

2.10

29.54

1.3

1.2

2.19

2.06

mmol/l

0.66

272

991

Other diseases of blood and blood-forming organs, wide

165

630

2.65

29.47

1.4

1.3

2.38

2.06

mmol/l

1.16

154

591

Hypertensive diseases (excluding secondary)

327

927

2.06

29.31

1.2

2.11

1.86

mmol/l

2.80

303

863

Other and unspecified myopathies

193

4.16

29.28

1.2

1.3

2.13

2.08

mmol/l

0.19

183

Sleep apnoea

564

2150

1.70

29.01

1.2

1.3

2.01

2.16

mmol/l

2.08

520

1986

Dysphagia

164

630

2.62

28.91

1.5

1.3

2.14

2.13

mmol/l

0.01

150

587

Asthma

429

1204

1.87

28.81

1.3

1.2

2.05

2.06

mmol/l

0.06

395

1119

Other functional intestinal disorders

298

1366

2.04

28.63

1.3

1.97

2.12

mmol/l

1.86

270

1260

Asthma, excluding more controls

418

1159

1.89

28.62

1.3

1.2

2.05

2.06

mmol/l

0.03

385

1079

Asthma (mode)

424

1216

1.87

28.60

1.3

1.2

2.05

2.06

mmol/l

0.07

390

1131

Benign neoplasm of brain and other parts of central nervous system

155

4.55

28.55

2.1

1.2

2.60

2.01

mmol/l

1.51

146

Transient ischemic attack

281

1091

2.10

28.46

1.2

1.3

2.03

2.25

mmol/l

2.76

260

1008

Neuromuscular dysfunction of bladder

220

3.88

28.32

1.3

1.2

2.07

2.06

mmol/l

0.05

204

Asthma, unspecified (mode)

298

1100

2.05

28.06

1.3

1.2

2.18

2.07

mmol/l

0.60

273

1025

Disorders of vestibular function (Vertigo)

286

1385

2.04

28.04

1.2

1.3

1.89

2.18

mmol/l

6.05

265

1279

Other disorders of lacrimal gland

236

1083

2.20

27.95

1.2

1.3

2.15

2.09

mmol/l

0.28

212

1005

Hypopituitarism

197

4.04

27.68

1.3

1.5

2.08

1.95

mmol/l

0.46

187

Visual impairment including blindness (binocular or monocular)

143

4.63

27.57

1.3

1.2

2.15

1.97

mmol/l

0.36

137

Abdominal and pelvic pain

585

1751

1.68

27.24

1.3

1.2

1.98

2.10

mmol/l

1.62

550

1613

Antihypertensive medication - note that there are other indications

412

1178

1.86

27.19

1.3

1.2

1.89

1.86

mmol/l

0.19

379

1104

Other systemic involvement of connective tissue (FG)

175

705

2.47

27.14

1.2

1.3

2.04

2.08

mmol/l

0.12

161

656

Examination and observation for other reasons

310

883

2.04

27.13

1.3

1.2

2.05

2.11

mmol/l

0.26

290

823

Other and unspecified visual disturbances

255

3.58

27.07

1.1

1.3

1.83

2.09

mmol/l

2.14

241

All influenza

168

675

2.51

27.01

1.2

2.11

1.97

mmol/l

0.55

152

635

Bipolar affective disorders

147

555

2.67

26.90

1.2

1.3

2.03

1.90

mmol/l

0.46

140

520

Disorders of lacrimal system

271

1330

2.05

26.73

1.3

2.14

2.10

mmol/l

0.20

247

1231

Other medical care

272

1197

2.05

26.71

1.6

1.2

2.53

2.09

mmol/l

2.99

255

1118

Factors influencing health status and contact with health services

166

304

2.75

26.70

1.3

1.1

2.05

2.00

mmol/l

0.26

158

282

Accidents

495

1418

1.75

26.65

1.3

1.98

2.09

mmol/l

1.16

456

1321

Other disorders of nervous system

139

4.62

26.65

1.6

1.2

2.20

2.21

mmol/l

0.02

131

Other intervertebral disc disorders

476

1642

1.75

26.61

1.2

1.3

1.96

2.17

mmol/l

2.79

439

1525

L04AX Other immunosuppressants

353

1905

1.86

26.49

1.2

1.3

2.15

2.06

mmol/l

0.41

330

1773

Other necrotizing vasculopathies

161

4.30

26.32

1.3

1.2

2.09

2.07

mmol/l

0.07

152

Spondylosis

311

1301

1.96

26.24

1.3

2.03

2.23

mmol/l

2.48

289

1215

Other necrotizing vasculopathies (FG)

129

4.74

26.20

1.3

2.10

2.07

mmol/l

0.06

123

Second line medication for Crohn's disease

363

1983

1.84

26.20

1.2

1.3

2.14

2.05

mmol/l

0.39

339

1841

Dental caries

179

722

2.40

26.02

1.3

1.2

2.08

2.12

mmol/l

0.15

166

682

Falls/tendency to fall

658

2050

1.61

25.96

1.3

2.01

2.05

mmol/l

0.38

615

1899

Fungal Sepsis

5.88

25.94

1.1

2.81

1.86

mmol/l

1.01

Hypothyroidism, strict autoimmune

409

1495

1.81

25.85

1.3

1.95

2.11

mmol/l

2.23

369

1386

Other specific joint derangements/joint disorders

467

1744

1.74

25.78

1.2

1.3

1.93

2.02

mmol/l

0.84

427

1614

Sleep disorders (combined)

672

2217

1.60

25.71

1.2

1.3

1.95

2.11

mmol/l

2.86

618

2051

Cystitis

503

1757

1.71

25.71

1.3

1.2

1.99

2.07

mmol/l

0.88

466

1627

Hypertension, essential

467

1517

1.75

25.65

1.2

1.3

2.16

1.99

mmol/l

1.92

432

1404

Abnormalities of heart beat

228

1049

2.14

25.45

1.2

1.3

2.01

2.12

mmol/l

0.46

213

973

Volume depletion

178

4.04

25.42

1.3

1.2

2.36

2.11

mmol/l

0.57

169

Cervicalgia

143

548

2.63

25.42

1.2

1.3

1.99

2.08

mmol/l

0.44

129

515

L04AA Selective immunosuppressants

167

691

2.44

25.29

1.2

1.3

2.27

2.00

mmol/l

0.65

156

647

Constipation

519

2161

1.67

25.08

1.3

2.05

2.11

mmol/l

0.65

478

2004

Alcohol use disorder, Swedish definition

339

1680

1.86

25.00

1.2

1.3

2.17

2.07

mmol/l

0.61

312

1565

Other external causes of accidental injury

487

1418

1.73

24.84

1.3

1.96

2.09

mmol/l

1.33

450

1321

Diseases of the musculoskeletal system and connective tissue

341

889

1.93

24.79

1.2

1.3

1.87

2.08

mmol/l

2.42

321

823

Other disorders of bladder

275

3.35

24.78

1.2

2.10

2.07

mmol/l

0.11

259

Other systemic involvement of connective tissue

179

772

2.34

24.68

1.2

1.3

2.04

2.05

mmol/l

0.04

165

711

358

1787

1.82

24.58

1.2

1.3

2.13

2.07

mmol/l

0.35

333

1660

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

217

1016

2.15

24.52

1.4

1.3

1.99

1.90

mmol/l

0.68

196

953

Supplementary factors related to causes of morbidity and mortality classified elsewhere

212

985

2.17

24.42

1.5

1.2

2.06

2.02

mmol/l

0.18

198

922

Pain in thoracic spine

111

381

2.94

24.36

1.5

1.4

1.85

2.06

mmol/l

1.69

106

360

External causes of morbidity and mortality

390

1069

1.83

24.34

1.4

1.2

1.96

2.09

mmol/l

1.15

360

991

Other and unspecified nonorganic psychotic disorders

153

621

2.49

24.18

1.2

1.3

2.12

1.91

mmol/l

0.82

138

574

Gastrointestinal diseases

388

1065

1.83

24.12

1.4

1.3

1.96

2.02

mmol/l

0.35

357

981

Neoplasms

495

1551

1.70

24.12

1.3

1.2

2.05

1.89

mmol/l

2.15

463

1440

Somatoform disorder

123

449

2.77

24.10

1.1

1.3

1.83

2.00

mmol/l

1.08

110

421

Non-selective monoamine reuptake inhibitors

212

952

2.16

24.05

1.3

1.2

2.05

2.15

mmol/l

0.66

196

886

Unspecified fall

305

1597

1.89

24.05

1.3

1.99

2.08

mmol/l

0.76

283

1475

371

1837

1.79

23.92

1.2

1.3

2.14

2.06

mmol/l

0.50

344

1707

Zoster [herpes zoster]

126

468

2.72

23.87

1.3

1.2

2.24

2.08

mmol/l

0.57

121

435

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

578

2350

1.61

23.85

1.4

1.2

2.19

2.03

mmol/l

1.37

531

2187

Type of accident

198

904

2.21

23.85

1.5

1.3

2.00

2.01

mmol/l

0.04

184

847

Sleep apnoea, including avohilmo

578

2243

1.60

23.30

1.2

1.3

2.03

2.13

mmol/l

1.12

534

2072

Cervical disc disorders

213

1011

2.12

23.23

1.4

1.3

2.03

2.17

mmol/l

0.94

199

944

Triptan medication for migraine, single purchase ok

476

1934

1.67

23.22

1.2

1.3

1.81

2.05

mmol/l

7.89

440

1805

Migraine, single triptan purchase ok & required. ICD-code if available is included

476

1934

1.67

23.22

1.2

1.3

1.81

2.05

mmol/l

7.89

440

1805

Other symptoms and signs involving the digestive system and abdomen

116

420

2.79

23.09

1.2

1.3

2.14

2.04

mmol/l

0.29

105

387

Caries of dentine

157

641

2.40

22.94

1.2

1.3

2.12

mmol/l

0.02

144

606

Degenerative diseases of the nervous system

187

606

2.28

22.94

1.2

2.00

2.31

mmol/l

3.51

172

553

Non-Hodgkin lymphoma, all

5.41

22.84

1.5

1.2

2.95

2.03

mmol/l

1.11

Unspecific neurodegenerative disorder

220

706

2.14

22.83

1.2

2.10

2.31

mmol/l

1.15

205

644

Sciatica+with lumbago

289

1409

1.90

22.74

1.2

1.3

1.93

2.19

mmol/l

3.63

267

1309

Mental and behavioural disorders due to alcohol, excluding acute intoxication

272

1414

1.92

22.68

1.2

1.3

2.19

2.08

mmol/l

0.65

248

1328

Pure hypercholesterolaemia

390

1452

1.76

22.65

1.3

2.12

2.14

mmol/l

0.09

362

1344

Other acute lower respiratory infections

319

1670

1.83

22.55

1.2

1.3

1.96

2.04

mmol/l

0.56

296

1556

Mental and behavioural disorders due to alcohol

311

1632

1.84

22.47

1.2

1.3

2.15

2.07

mmol/l

0.45

287

1524

Endocrine, nutritional and metabolic diseases

483

1462

1.68

22.42

1.2

2.01

1.93

mmol/l

0.81

444

1367

Disorders of lipoprotein metabolism and other lipidaemias

438

1600

1.70

22.35

1.3

2.18

2.12

mmol/l

0.31

403

1482

Diseases of inner ear

310

1641

1.84

22.24

1.2

1.3

1.91

2.20

mmol/l

5.92

287

1515

Speech and linguistic disorders, excluding more controls

166

3.84

22.09

1.4

1.3

1.99

1.77

mmol/l

1.06

155

Mycoses

176

791

2.24

22.08

1.3

2.51

2.03

mmol/l

1.34

160

744

Other joint disorders

543

1778

1.62

22.00

1.2

1.3

1.89

2.03

mmol/l

2.23

512

1644

Disorders of eyelid, lacrimal system and orbit

492

2306

1.63

21.97

1.3

1.2

2.13

2.08

mmol/l

0.31

449

2142

Other viral diseases

209

1009

2.08

21.68

1.2

1.3

1.97

1.89

mmol/l

0.41

197

939

Emotional disorders starting during childhood or adolecense, excluding more controls

5.07

21.63

1.5

1.2

1.74

1.60

mmol/l

0.57

Diarrhoea and gastroenteritis of presumed infectious origin

592

2511

1.56

21.63

1.3

1.2

1.96

2.09

mmol/l

2.27

545

2326

Acute bronchitis

243

1218

1.97

21.56

1.2

1.3

1.91

2.03

mmol/l

1.14

224

1124

Retention of urine

198

764

2.14

21.37

1.4

1.2

2.18

2.21

mmol/l

0.09

180

714

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

314

1698

1.80

21.36

1.2

1.3

1.97

2.14

mmol/l

1.98

293

1584

Alcohol use disorder, ICD-based

249

1297

1.93

21.02

1.2

1.3

2.19

2.04

mmol/l

0.88

226

1219

Diseases of the respiratory system

354

988

1.80

20.96

1.4

1.2

2.04

mmol/l

0.01

328

922

Tick-borne viral encephalitis

56.07

20.81

1.3

1.6

2.17

2.25

mmol/l

—

Asthma (only as main-diagnosis), excluding more controls

358

1159

1.77

20.75

1.3

1.2

1.96

2.06

mmol/l

0.65

326

1079

Other CVD (FINNGEN)

174

3.46

20.72

1.4

1.2

2.08

1.96

mmol/l

0.38

162

Other and unspecified nerve root and plexus disorders, also in other diseases

133

545

2.46

20.67

1.2

1.3

1.86

2.00

mmol/l

0.84

122

514

Nutritional anaemias

278

1456

1.85

20.46

1.2

1.3

2.13

2.12

mmol/l

0.05

252

1353

Tick-borne viral encephalitis

41.12

20.44

1.3

1.4

2.15

2.09

mmol/l

—

Radiculopathy

106

391

2.73

20.42

1.1

1.3

2.00

2.15

mmol/l

0.83

367

Hypertension

457

1570

1.65

20.38

1.2

1.3

2.15

1.98

mmol/l

1.95

423

1453

Hypertensive diseases

457

1571

1.65

20.35

1.2

1.3

2.15

1.98

mmol/l

1.96

423

1454

Use of hypnotics and sedatives

619

2329

1.53

20.31

1.3

1.2

2.06

2.09

mmol/l

0.19

572

2163

Inflammatory diseases of female pelvic organs

359

1530

1.73

20.28

1.3

1.93

2.04

mmol/l

1.41

318

1427

Transport accidents

270

1249

1.87

20.15

1.2

1.3

1.93

2.08

mmol/l

1.17

251

1164

Other bacterial intestinal infections

117

457

2.58

20.13

1.3

2.07

2.11

mmol/l

0.17

107

423

Lumbar disc prolapse

352

1563

1.73

20.13

1.2

1.3

1.93

2.17

mmol/l

3.15

328

1450

Iron deficiency anaemia

244

1264

1.91

19.99

1.2

1.3

2.12

2.09

mmol/l

0.14

220

1175

Other strabismus

153

675

2.28

19.95

1.3

1.2

1.87

1.92

mmol/l

0.32

138

635

Presence of other functional implants

310

1198

1.80

19.83

1.2

1.3

2.34

2.23

mmol/l

0.39

286

1114

Intestinal infectious diseases

657

2504

1.50

19.82

1.3

1.2

1.99

2.09

mmol/l

1.54

609

2321

Asthma (only as main-diagnosis)

361

1204

1.74

19.80

1.3

1.2

1.96

2.06

mmol/l

0.70

328

1119

Lung diseases due to external agents

321

2.89

19.69

1.7

1.2

2.35

2.14

mmol/l

0.62

300

Open wound of head

302

1644

1.78

19.58

1.3

1.2

2.00

2.10

mmol/l

0.92

283

1529

Viral infections characterized by skin and mucous membrane lesions

500

2739

1.57

19.52

1.3

2.06

2.05

mmol/l

0.07

467

2536

Arthropathies

549

1781

1.57

19.47

1.2

1.3

1.95

2.03

mmol/l

0.85

515

1647

Other and unspecified iron deficiency

198

980

2.03

19.37

1.2

1.3

2.09

2.06

mmol/l

0.12

177

908

Dementia in other diseases classified elsewhere

5.16

19.34

1.2

2.00

2.06

mmol/l

0.16

Other extrapyramidal and movement disorders in other diseases

148

656

2.27

19.28

1.2

1.3

2.01

2.10

mmol/l

0.53

139

612

Dissociative [conversion] disorders

4.93

19.25

1.2

1.97

1.90

mmol/l

0.11

Diseases of the skin and subcutaneous tissue

578

1883

1.54

19.21

1.3

1.2

2.04

2.05

mmol/l

0.07

543

1741

Triptan medication for migraine, min. 3 purchases

352

1578

1.71

19.13

1.2

1.3

1.79

1.97

mmol/l

3.42

328

1471

All chronic kidney diseases

289

1316

1.80

19.13

1.2

2.32

2.05

mmol/l

1.27

267

1220

Other mental disorders due to brain damage and dysfunction and to physical disease

237

3.20

19.09

1.3

1.98

2.14

mmol/l

0.99

217

Certain disorders involving the immune mechanism

133

567

2.37

18.99

1.5

1.3

2.18

2.04

mmol/l

0.58

128

534

Other shoulder lesions

223

3.27

18.95

1.3

1.4

1.85

2.07

mmol/l

1.41

210

Sensorineural hearing loss

395

1621

1.66

18.86

1.3

2.18

2.15

mmol/l

0.13

362

1505

Dementia in Alzheimer disease

250

2.96

18.70

1.2

2.03

2.28

mmol/l

1.79

224

Vocal cord dysfunction

249

3.01

18.68

1.3

2.08

1.90

mmol/l

0.51

235

Substance use, excluding alcohol

140

617

2.29

18.52

1.3

2.13

1.97

mmol/l

0.94

129

577

Other viral diseases

245

1314

1.86

18.52

1.2

1.3

1.93

1.90

mmol/l

0.12

231

1230

Disorders of mineral metabolism

188

3.45

18.34

1.3

2.25

2.08

mmol/l

0.37

177

Other and unspecified disorders of skin and subcutaneous tissue

147

3.80

18.16

1.1

1.3

1.86

2.11

mmol/l

1.12

138

Other disorders of eye and adnexa

105

411

2.58

18.06

1.3

1.86

2.00

mmol/l

1.04

386

Hypothyroidism, drug reimbursement

174

3.18

18.05

1.3

1.1

2.06

1.75

mmol/l

2.37

164

Unspecified mental disorder

250

1373

1.83

17.97

1.2

1.3

2.10

1.99

mmol/l

0.55

231

1286

Nonorganic sleeping disorders, excluding more controls

118

492

2.42

17.72

1.3

1.2

1.71

1.93

mmol/l

3.40

108

461

Diseases of liver

201

1038

1.95

17.52

1.3

2.34

2.06

mmol/l

1.49

186

973

Meningitis, viral

35.77

17.52

1.5

1.1

2.52

1.65

mmol/l

—

N06DA Anticholinesterases

166

621

2.12

17.47

1.2

2.12

2.30

mmol/l

0.71

155

565

Use of anticholinesterases

166

621

2.12

17.47

1.2

2.12

2.30

mmol/l

0.71

155

565

Use of levodopa decarboxylase inhibitor

315

2.79

17.46

1.1

1.2

1.91

2.20

mmol/l

3.05

296

Infections of the skin and subcutaneous tissue

342

2048

1.66

17.45

1.2

1.3

2.03

2.04

mmol/l

0.08

319

1899

Leisure time condition

126

546

2.33

17.38

1.6

1.3

1.93

2.02

mmol/l

0.50

115

509

Disorders of the thyroid gland

530

2280

1.52

17.29

1.3

1.2

2.03

2.06

mmol/l

0.23

483

2125

Injury, poisoning and certain other consequences of external causes

297

836

1.79

17.25

1.4

1.2

2.00

mmol/l

0.01

275

770

Special screening examination for infectious and parasitic diseases

142

466

2.26

17.18

1.2

1.70

1.99

mmol/l

2.38

130

438

Personality disorders

185

936

1.99

17.14

1.2

1.3

1.90

1.93

mmol/l

0.25

162

878

Follow-up examination after treatment for conditions other than malignant neoplasms

215

737

1.94

17.14

1.2

1.98

2.08

mmol/l

0.60

197

687

Hypothyroidism, other/unspecified

499

2146

1.53

17.11

1.3

1.2

2.01

2.06

mmol/l

0.48

452

1996

Other disorders of ear

500

2142

1.53

17.09

1.2

1.3

2.11

2.10

mmol/l

0.01

462

1994

Hypothyreosis and Thyroxine purchase for inclusion criteria

516

2231

1.52

17.06

1.3

2.02

2.07

mmol/l

0.33

468

2076

Focal brain injury

5.93

16.97

1.5

1.1

2.76

2.03

mmol/l

0.80

Kela-code for severe mental illness

224

1212

1.86

16.95

1.2

1.3

2.06

2.00

mmol/l

0.25

206

1135

Other disorders of skin and subcutaneous tissue

372

2048

1.62

16.95

1.3

2.17

2.12

mmol/l

0.25

333

1905

Erysipelas

273

1378

1.76

16.95

1.2

1.3

2.25

2.05

mmol/l

1.62

251

1280

366

2.62

16.90

1.8

1.2

1.96

1.95

mmol/l

0.03

344

Finngen Rheumatological endpoints

556

2118

1.50

16.58

1.2

1.3

1.98

2.04

mmol/l

0.65

518

1966

Presence of other devices

130

582

2.24

16.43

1.4

1.2

2.48

2.21

mmol/l

0.91

117

543

Renal failure

236

1152

1.82

16.40

1.2

1.3

2.24

2.16

mmol/l

0.33

213

1079

Poisoning by medicine

150

715

2.11

16.39

1.2

1.3

1.91

1.94

mmol/l

0.16

135

670

Disorders of adult personality and behaviour

191

993

1.94

16.38

1.2

1.3

1.91

mmol/l

0.02

167

931

Fibromyalgia

228

3.06

16.36

1.3

1.5

1.98

2.03

mmol/l

0.07

216

Generalized anxiety disorder

113

480

2.37

16.34

1.1

1.2

1.76

1.90

mmol/l

1.86

108

445

Genitourinary diseases

336

997

1.70

16.34

1.3

1.2

1.91

1.99

mmol/l

0.66

315

920

Insulin, intermediate and long-acting

299

1727

1.69

16.28

1.2

1.3

2.40

2.05

mmol/l

5.18

277

1609

264

1506

1.75

16.28

1.2

1.3

2.06

1.97

mmol/l

0.49

247

1404

Osteopathies and chondropathies

306

1703

1.68

16.25

1.2

1.3

2.02

2.12

mmol/l

0.87

280

1579

Infections with a predominantly sexual mode of transmission

251

1323

1.78

16.22

1.2

1.3

1.80

1.89

mmol/l

1.15

232

1239

Other diseases of intestines

607

2365

1.46

16.19

1.3

1.98

2.06

mmol/l

0.91

567

2199

Type 2 diabetes, wide definition

423

1727

1.57

16.15

1.2

1.3

2.42

2.07

mmol/l

3.27

384

1602

Schizophrenia, schizotypal and delusional disorders

198

1048

1.90

16.09

1.2

1.3

2.13

1.97

mmol/l

0.76

179

979

Cough

225

1174

1.82

15.89

1.3

2.05

2.13

mmol/l

0.41

207

1087

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

203

1090

1.87

15.79

1.4

1.3

2.17

2.02

mmol/l

1.00

188

1011

Other disorders of glucose regulation and pancreatic internal secretion

212

3.10

15.78

1.1

1.3

2.04

2.02

mmol/l

0.07

201

Injuries to the thorax

245

1393

1.77

15.73

1.3

2.07

2.11

mmol/l

0.17

219

1296

Poisoning by drugs, medicaments and biological substances

160

794

2.03

15.71

1.2

1.3

1.90

1.95

mmol/l

0.36

145

744

Conductive and sensorineural hearing loss

407

1752

1.57

15.71

1.3

2.18

2.14

mmol/l

0.22

373

1627

Schizophrenia or delusion

196

1045

1.89

15.59

1.2

1.3

2.13

1.97

mmol/l

0.75

177

976

Pain and other conditions associated with female genital organs and menstrual cycle

141

612

2.13

15.57

1.2

1.89

1.94

mmol/l

0.21

128

567

Hyperlipidaemia, other/unspecified

194

945

1.90

15.55

1.2

1.3

2.15

2.22

mmol/l

0.37

179

871

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

239

834

1.82

15.53

1.2

2.16

1.86

mmol/l

3.29

225

779

Suicide or other Intentional self-harm

163

819

2.00

15.47

1.3

2.01

1.96

mmol/l

0.28

144

767

Problems related to lifestyle

280

2.78

15.39

1.4

1.2

2.19

1.97

mmol/l

1.28

261

Bacterial intestinal infections, IBD co-morbidities

113

494

2.30

15.32

1.3

2.08

2.07

mmol/l

0.06

103

460

Diseases of arteries, arterioles and capillaries (FINNGEN)

126

386

2.27

15.32

1.3

1.2

2.31

1.96

mmol/l

2.63

116

365

Dermatitis and eczema

616

2662

1.44

15.28

1.3

1.2

2.07

2.06

mmol/l

0.05

569

2465

Asthma-related infections

329

2000

1.62

15.17

1.3

2.11

2.05

mmol/l

0.31

304

1857

Asthma, hospital admission 2, infections

329

2000

1.62

15.17

1.3

2.11

2.05

mmol/l

0.31

304

1857

Chronic apical periodontitis

623

2477

1.44

15.09

1.2

1.3

2.08

2.05

mmol/l

0.20

568

2298

Other problems related to primary support group, including family circumstances

353

2.53

15.07

1.6

1.2

1.84

1.83

mmol/l

0.02

330

Injuries to the ankle and foot

406

2349

1.54

15.04

1.2

1.3

1.87

2.02

mmol/l

2.22

372

2186

Missing teeth due to accident, extraction or parodontitis

309

1782

1.64

15.01

1.4

1.3

2.13

2.17

mmol/l

0.20

274

1657

Heart failure, not strict

384

1663

1.57

14.90

1.4

1.3

2.27

2.15

mmol/l

0.92

361

1538

Spinal stenosis

246

1067

1.76

14.89

1.3

2.19

2.27

mmol/l

0.42

229

994

Urticaria and erythema

221

1241

1.79

14.88

1.2

1.3

2.08

1.97

mmol/l

0.41

195

1161

Other bacterial intestinal infections

133

629

2.13

14.88

1.3

2.06

2.08

mmol/l

0.09

121

590

Post-traumatic stress disorder

225

2.97

14.86

1.3

1.2

1.86

1.82

mmol/l

0.08

212

Internal derangement of knee

214

1185

1.81

14.84

1.2

1.3

1.90

2.09

mmol/l

2.47

197

1097

Emotional disorders starting during childhood or adolescence

129

3.67

14.77

1.4

1.2

1.72

1.68

mmol/l

0.14

118

Hypoglycaemia, other or unspecified

174

3.26

14.77

1.1

1.4

2.03

2.00

mmol/l

0.07

165

Decubitus ulcer and pressure area

117

3.81

14.68

1.7

1.2

2.27

2.05

mmol/l

0.46

110

Candidiasis

176

926

1.91

14.62

1.2

1.3

2.12

1.99

mmol/l

0.85

157

868

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

119

543

2.21

14.60

1.2

1.3

1.95

1.94

mmol/l

0.05

104

508

Polyarthropathies

370

1533

1.58

14.60

1.2

1.3

2.24

2.07

mmol/l

0.89

345

1417

Encephalopathy

16.26

14.60

1.2

1.1

1.86

1.77

mmol/l

0.25

Insulin, fast-acting

203

1118

1.82

14.56

1.2

1.3

2.37

2.00

mmol/l

3.43

185

1050

Shoulder lesions

400

1565

1.55

14.39

1.3

1.97

2.20

mmol/l

5.28

368

1448

Insulin, combination of fast acting with intermediate-acting or long-acting

324

1854

1.60

14.31

1.2

1.3

2.39

2.05

mmol/l

5.52

299

1727

Other and unspecified effects of external causes

175

927

1.90

14.26

1.2

1.3

1.78

1.95

mmol/l

3.04

162

869

Heterophoria

194

3.08

14.17

1.4

1.2

1.89

1.93

mmol/l

0.14

179

Any event in cancer register

498

1991

1.48

14.09

1.4

1.3

2.21

2.00

mmol/l

2.73

468

1855

Polycystic ovarian syndrome, consortium definition

393

1504

1.55

14.08

1.4

1.2

2.07

2.00

mmol/l

0.51

370

1390

Insulin medication

324

1710

1.60

14.02

1.2

1.3

2.39

2.02

mmol/l

6.03

299

1588

Other heart diseases

253

961

1.72

13.99

1.4

1.2

2.15

1.85

mmol/l

2.61

237

900

Disorders of psychological development

354

2.43

13.89

1.3

1.84

1.76

mmol/l

0.38

330

Mycoses

469

2784

1.47

13.82

1.2

1.3

2.15

2.05

mmol/l

0.53

424

2591

Coagulation defects, purpura and other haemorrhagic conditions

122

581

2.11

13.47

1.4

1.3

2.32

1.98

mmol/l

0.98

111

540

Exclusions for E4_PCOS_CONSORTIUM

408

1686

1.52

13.46

1.2

1.3

2.04

1.98

mmol/l

0.50

373

1558

Insulin, fast-acting or short human

204

1157

1.77

13.32

1.2

1.3

2.38

2.02

mmol/l

3.18

186

1085

Dermatitis

326

2080

1.57

13.30

1.3

2.09

mmol/l

0.00

302

1928

Abnormal findings on examination of blood, without diagnosis

242

1320

1.69

13.22

1.2

1.3

2.22

2.12

mmol/l

0.56

226

1231

Specific personality disorders

155

811

1.92

13.16

1.2

1.3

1.86

1.91

mmol/l

0.39

134

759

severe traumatic brain injury, does not include concussion

123

593

2.09

13.14

1.4

1.3

2.30

2.14

mmol/l

0.56

110

555

Other disorders of skin and subcutaneous tissue, not elsewhere classified

376

2.39

13.13

1.1

1.3

2.01

2.10

mmol/l

0.29

354

Other and unspecified tonsillitis

201

951

1.78

13.13

1.2

1.80

1.92

mmol/l

1.04

183

895

Injuries to the abdomen, lower back, lumbar spine and pelvis

215

1230

1.74

13.12

1.2

1.3

2.05

2.04

mmol/l

0.04

196

1144

Noninfective enteritis and colitis

260

1582

1.65

13.07

1.3

2.00

2.03

mmol/l

0.14

241

1475

Candidiasis

384

2.36

13.00

1.2

1.3

2.31

2.03

mmol/l

1.09

357

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

215

2.87

12.99

1.1

1.2

2.04

2.00

mmol/l

0.07

197

Functional dyspepsia

151

787

1.93

12.97

1.1

1.3

2.03

2.04

mmol/l

0.06

145

740

Panic disorder

100

447

2.25

12.95

1.2

1.3

1.87

1.89

mmol/l

0.07

419

Irritable bowel syndrome

165

888

1.87

12.85

1.2

1.3

1.84

2.01

mmol/l

2.80

148

827

Coxibs

158

422

1.98

12.80

1.2

1.83

2.17

mmol/l

4.41

148

389

Benign paroxysmal vertigo

156

826

1.90

12.79

1.2

1.3

1.93

2.13

mmol/l

1.74

149

768

Diseases of pulp and periapical tissues, including avohilmo

577

2117

1.41

12.77

1.2

1.3

2.00

2.06

mmol/l

0.57

534

1971

Erysipelas

340

1682

1.55

12.65

1.3

2.19

2.05

mmol/l

1.32

316

1554

Convergent concomitant strabismus

145

3.28

12.60

1.1

1.2

1.88

1.83

mmol/l

0.10

136

Zoster [herpes zoster]

251

1509

1.64

12.49

1.3

2.13

2.15

mmol/l

0.08

232

1386

Other viral diseases, not elsewhere classified

122

598

2.05

12.42

1.2

1.3

1.97

1.96

mmol/l

0.02

116

559

Irregular menses

269

1312

1.63

12.38

1.3

1.2

1.96

1.95

mmol/l

0.08

247

1215

Dental pulpitis, including avohilmo

512

2337

1.43

12.35

1.3

2.01

2.03

mmol/l

0.13

472

2182

Hypotension

393

2.30

12.33

1.3

2.06

2.17

mmol/l

0.49

368

Other and unspecified urticaria

124

616

2.03

12.27

1.2

1.3

2.12

1.93

mmol/l

0.46

112

573

Excessive, frequent and irregular menstruation

232

743

1.72

12.23

1.4

1.2

1.99

1.98

mmol/l

0.06

221

689

Dyspnoea

469

2421

1.43

12.01

1.2

1.3

2.02

2.11

mmol/l

0.70

431

2249

Speech and linguistic disorders

253

2.60

11.99

1.4

1.3

1.99

1.71

mmol/l

1.58

232

Herpesviral [herpes simplex] infections

148

789

1.89

11.92

1.2

1.3

2.18

1.95

mmol/l

0.71

141

735

Diabetic maculopathy, excluding more controls

295

2.50

11.92

1.1

1.3

2.32

1.87

mmol/l

4.44

280

Diabetic retinopathy, strict definition

400

2.20

11.88

1.1

1.2

2.33

2.30

mmol/l

0.06

364

Exposure to other specified factors

413

2613

1.45

11.76

1.3

1.94

2.05

mmol/l

1.43

380

2434

Abnormal findings on diagnostic imaging of other body structures

358

2.34

11.74

1.3

1.99

2.13

mmol/l

0.59

334

Urticaria

179

1020

1.76

11.61

1.3

2.04

1.94

mmol/l

0.32

159

960

Superficial injury of lower leg

146

782

1.88

11.61

1.2

1.3

1.93

1.98

mmol/l

0.16

133

730

Chronic kidney disease

146

767

1.87

11.55

1.2

1.3

2.34

2.20

mmol/l

0.40

132

719

Other CVD

100

469

2.14

11.54

1.3

1.2

2.06

2.17

mmol/l

0.47

440

Secondary hypertension

156

3.07

11.54

1.2

2.14

1.87

mmol/l

0.50

150

Polyuria

120

603

2.00

11.53

1.3

1.2

2.08

2.14

mmol/l

0.20

112

562

Type 1 diabetes

149

805

1.86

11.48

1.2

1.3

2.30

1.88

mmol/l

1.33

136

757

Familial hypercholesterolemia

337

2.36

11.46

1.2

2.15

2.14

mmol/l

0.02

320

Cardiac arrhythmias

302

1261

1.56

11.40

1.2

2.07

1.90

mmol/l

1.33

282

1185

Enterocolitis due to Clostridium difficile

254

2.58

11.39

1.3

2.06

mmol/l

0.00

238

Sequelae of injuries of head

134

3.25

11.38

1.7

1.4

2.00

2.05

mmol/l

0.13

129

Other noninfective gastroenteritis and colitis

143

767

1.87

11.30

1.3

2.09

2.01

mmol/l

0.37

127

718

Other nutritional deficiencies

356

2265

1.48

11.29

1.1

1.3

2.11

2.01

mmol/l

0.62

322

2116

Emotionally unstable personality disorder

409

2.22

11.28

1.1

1.4

1.87

1.85

mmol/l

0.13

382

Disorders of lens

329

1347

1.53

11.25

1.3

2.17

2.16

mmol/l

0.07

314

1251

Dystonia

135

3.23

11.24

1.2

1.4

1.73

2.14

mmol/l

1.99

129

Emotional disorders and disorders of social functioning with onset specific to childhood

153

3.06

11.20

1.4

1.2

1.73

1.68

mmol/l

0.17

140

Other acute disseminated demyelination

9.65

11.15

1.1

1.3

1.71

1.80

mmol/l

0.28

Disorders of choroid and retina

395

1927

1.46

11.09

1.3

2.21

2.14

mmol/l

0.54

362

1786

Benign neoplasms

531

2103

1.39

11.06

1.3

2.03

2.01

mmol/l

0.11

497

1957

Infections with a predominantly sexual mode of transmission

185

1080

1.72

10.99

1.2

1.3

1.81

1.91

mmol/l

1.15

170

1018

Other infectious diseases

174

2.90

10.96

1.3

1.91

2.02

mmol/l

0.66

164

Diabetic retinopathy, excluding more controls

131

372

1.98

10.92

1.2

2.22

2.25

mmol/l

0.13

120

339

Injuries to the wrist and hand

538

2709

1.38

10.90

1.2

1.3

1.93

2.08

mmol/l

2.17

496

2518

Disorders of skin appendages

263

1681

1.57

10.89

1.3

1.97

1.98

mmol/l

0.04

246

1567

Acute renal failure

112

564

2.00

10.73

1.3

1.2

2.24

2.15

mmol/l

0.24

100

530

Amblyopia ex anopsia

3.63

10.66

1.5

1.4

1.87

1.79

mmol/l

0.31

Obesity related asthma

186

1099

1.70

10.64

1.2

1.3

2.14

2.07

mmol/l

0.27

173

1027

Use of rivastigmine

280

2.44

10.62

1.2

2.23

2.19

mmol/l

0.08

257

Other and unspecified dermatitis

267

1731

1.55

10.46

1.3

2.08

2.09

mmol/l

0.08

249

1619

Osteoporosis

126

622

1.90

10.39

1.2

1.3

2.14

2.20

mmol/l

0.24

116

570

Glomerular diseases

104

518

2.02

10.30

1.1

1.3

2.12

2.08

mmol/l

0.14

488

Inflammatory disease of uterus

412

2.15

10.28

1.1

1.3

1.85

1.91

mmol/l

0.33

390

Other arthritis (FG)

163

938

1.75

10.28

1.2

1.3

2.23

2.06

mmol/l

0.37

158

871

Other specified/unspecified arthritis

142

786

1.81

10.22

1.2

1.3

2.09

2.07

mmol/l

0.02

137

727

Malignant neoplasm

434

1812

1.42

10.21

1.4

1.3

2.19

2.06

mmol/l

1.33

405

1680

Acute pharyngitis

444

2.09

10.09

1.3

1.87

1.95

mmol/l

0.25

416

Injuries to the shoulder and upper arm

428

2458

1.41

10.03

1.3

2.10

2.11

mmol/l

0.05

401

2270

Superficial injury of head

122

649

1.89

9.97

1.1

1.3

2.02

2.03

mmol/l

0.04

113

605

Other viral diseases, not elsewhere classified

157

898

1.75

9.93

1.2

1.3

1.90

1.91

mmol/l

0.05

150

835

Alcohol dependence

138

765

1.81

9.91

1.2

1.3

2.01

2.06

mmol/l

0.33

125

718

Undetermined asthma, excluding more controls

284

2.37

9.90

1.3

1.2

2.11

2.01

mmol/l

0.26

267

Care involving dialysis

185

2.73

9.82

1.3

1.2

2.02

2.07

mmol/l

0.13

175

Hypothyroidism, strict autoimmune, 3 medication purchases required

432

2081

1.40

9.82

1.3

1.98

2.06

mmol/l

0.82

390

1938

Type 1 diabetes, wide definition, subgroup 1

124

667

1.87

9.78

1.2

1.3

2.16

1.86

mmol/l

3.74

112

631

Heart failure and antihypertensive medication

122

416

1.93

9.78

1.4

1.2

2.25

2.05

mmol/l

0.69

113

393

Caries of dentine, including avohilmo

403

1442

1.43

9.63

1.3

2.04

2.12

mmol/l

0.59

379

1342

Malignant neoplasm, wide definition for exclusion

446

1875

1.40

9.61

1.4

1.3

2.18

2.05

mmol/l

1.47

417

1742

Undetermined asthma

288

2.34

9.61

1.3

1.2

2.11

2.01

mmol/l

0.29

270

Complications of internal orthopaedic prosthetic devices, implants and grafts

108

560

1.94

9.56

1.4

1.2

2.11

2.15

mmol/l

0.12

103

513

Fracture of rib(s), sternum and thoracic spine

148

847

1.75

9.55

1.4

1.2

1.96

2.13

mmol/l

1.41

136

796

Menorrhagia

192

636

1.68

9.54

1.5

1.2

2.08

2.04

mmol/l

0.16

182

588

Behavioural syndromes associated with physiological disturbances and physical factors

484

2512

1.37

9.52

1.2

1.3

1.91

2.08

mmol/l

2.25

448

2324

Dental operations

295

1000

1.52

9.51

1.3

1.98

2.20

mmol/l

2.75

279

922

Glomerular disorders in diseases classified elsewhere

315

2.27

9.50

1.1

1.3

2.14

2.05

mmol/l

0.31

298

Other and unspecified drugs and medicaments

230

2.50

9.43

1.1

1.3

2.05

1.99

mmol/l

0.10

214

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

210

1316

1.59

9.41

1.2

1.3

1.78

1.91

mmol/l

1.67

191

1237

Diabetic maculopathy

303

2.26

9.38

1.1

1.2

2.32

2.31

mmol/l

0.02

277

Brachial plexus disorders

267

2.38

9.37

1.2

1.4

1.97

1.91

mmol/l

0.22

250

Injuries to the knee and lower leg

624

2624

1.32

9.35

1.2

1.3

2.00

2.07

mmol/l

0.82

590

2423

Use of donepezil

390

2.10

9.30

1.1

1.2

2.12

2.18

mmol/l

0.12

356

Other retinal disorders

300

1582

1.48

9.29

1.3

2.18

2.17

mmol/l

0.07

275

1466

All influenza (not pneumonia)

396

2.11

9.27

1.2

1.3

2.11

1.95

mmol/l

0.34

369

Hypermobility syndrome

141

2.94

9.25

1.3

2.30

1.86

mmol/l

0.49

133

Hyperkinetic disorders, excluding more controls

275

2.31

9.15

1.1

1.3

1.61

1.73

mmol/l

1.30

259

Dental caries, including avohilmo

372

1327

1.44

9.14

1.3

2.06

2.12

mmol/l

0.44

351

1233

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

130

643

1.81

9.12

1.2

1.3

1.71

1.73

mmol/l

0.11

118

605

Other diseases of the respiratory system

102

529

1.94

9.06

1.4

1.3

2.16

2.15

mmol/l

0.02

496

Other respiratory disorders and diseases

102

529

1.94

9.06

1.4

1.3

2.16

2.15

mmol/l

0.02

496

Other heart diseases, wide

495

2236

1.36

8.99

1.3

2.08

2.03

mmol/l

0.42

462

2079

Chronic sinusitis

219

1408

1.56

8.96

1.2

1.3

1.99

2.10

mmol/l

0.90

197

1318

Temporomandibular joint disorders, including avohilmo

243

1579

1.52

8.90

1.2

1.3

1.91

1.95

mmol/l

0.21

219

1473

Rheumatism, unspecified

337

2.18

8.89

1.4

2.11

2.16

mmol/l

0.10

315

Senile cataract

286

1176

1.49

8.88

1.3

2.23

2.20

mmol/l

0.14

272

1092

Type 1 diabetes, wide definition

125

696

1.80

8.87

1.2

1.3

2.16

1.87

mmol/l

3.53

113

656

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

499

1.96

8.84

1.2

1.3

1.87

1.92

mmol/l

0.27

472

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

165

984

1.66

8.80

1.4

1.2

1.79

1.88

mmol/l

0.96

150

919

Unspecified haematuria

194

1006

1.60

8.72

1.2

1.3

2.27

2.18

mmol/l

0.33

182

934

Other infectious diseases

221

2.46

8.70

1.2

1.3

1.95

2.08

mmol/l

0.57

208

Tetraplegia

12.15

8.68

4.2

1.1

1.88

1.71

mmol/l

0.26

Asthma, hospital admissions 3, pneumonia

177

1090

1.63

8.66

1.3

2.21

2.08

mmol/l

0.52

158

1015

Asthma-related pneumonia or sepsis

177

1090

1.63

8.66

1.3

2.21

2.08

mmol/l

0.52

158

1015

Obesity due to excess calories

249

1661

1.50

8.65

1.1

1.3

2.11

1.99

mmol/l

0.62

231

1552

Other female pelvic inflammatory diseases

448

2.00

8.64

1.2

1.3

1.95

2.06

mmol/l

0.56

421

Alzheimer disease

128

522

1.80

8.61

1.2

2.04

2.24

mmol/l

1.77

118

470

Parkinson's disease, including avohilmo

388

2.07

8.60

1.2

1.94

2.18

mmol/l

2.44

366

Fracture of skull and facial bones

112

611

1.84

8.54

1.4

1.3

2.04

2.02

mmol/l

0.09

577

Asthma-related pneumonia

176

1088

1.62

8.49

1.3

2.20

2.08

mmol/l

0.46

157

1013

Parkinson's disease

364

2.10

8.45

1.2

1.94

2.18

mmol/l

2.31

345

Other diseases of upper respiratory tract

555

2187

1.32

8.41

1.2

1.3

1.92

2.12

mmol/l

4.90

508

2027

Abnormal findings on diagnostic imaging of lung

216

1347

1.54

8.39

1.3

2.19

2.24

mmol/l

0.22

204

1248

Pain associated with micturition

320

2.17

8.35

1.5

1.3

1.97

2.05

mmol/l

0.33

299

Fracture of lumbar spine and pelvis

105

565

1.86

8.33

1.2

1.3

2.00

2.09

mmol/l

0.40

522

Diseases of middle ear and mastoid

312

1783

1.43

8.32

1.2

1.3

2.10

1.94

mmol/l

0.86

292

1660

Disorders of refraction and accommodation

144

850

1.69

8.27

1.4

1.2

1.98

1.93

mmol/l

0.23

133

799

Disorders of muscles

245

2.34

8.26

1.1

1.4

1.79

2.00

mmol/l

1.53

227

Cutaneous abscess, furuncle and carbuncle

138

810

1.71

8.22

1.3

2.08

1.95

mmol/l

0.82

129

758

Sequelae of external causes of morbidity and mortality

128

736

1.75

8.21

1.6

1.3

2.22

2.09

mmol/l

0.50

121

691

Alzheimer disease, including avohilmo

149

619

1.70

8.20

1.2

2.12

2.31

mmol/l

0.94

137

562

Striking against or struck by other objects

180

1132

1.59

8.16

1.2

1.3

1.83

1.98

mmol/l

1.68

165

1060

Pulmonary heart disease

135

790

1.72

8.12

1.4

1.3

2.22

2.12

mmol/l

0.48

127

736

Diabetic neuropathy

277

2.24

8.11

1.3

1.2

2.32

2.43

mmol/l

0.33

259

Sub-endpoint used in defining T1D endpoints

151

896

1.66

8.10

1.2

1.3

2.31

1.97

mmol/l

0.97

137

841

Pulmonary embolism

135

791

1.71

8.09

1.4

1.3

2.22

2.12

mmol/l

0.48

127

737

Chronic lower respiratory diseases

635

2623

1.29

8.04

1.3

2.01

2.06

mmol/l

0.43

586

2438

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

200

2.47

7.98

1.2

1.4

2.13

1.83

mmol/l

0.90

187

Use of pramipexole

108

596

1.82

7.98

1.3

2.11

2.13

mmol/l

0.07

559

Diabetic nephropathy, excluding more controls

286

2.11

7.97

1.1

1.2

2.56

2.22

mmol/l

0.37

261

Covid-19 suspected case

124

713

1.75

7.97

1.2

1.3

1.82

1.90

mmol/l

0.79

118

662

Fentanyl

206

2.44

7.93

1.3

2.58

2.03

mmol/l

1.78

194

Sleep disorders

455

2458

1.34

7.93

1.2

1.3

1.87

2.08

mmol/l

3.48

421

2277

Cellulitis

117

664

1.77

7.88

1.2

1.3

2.03

2.00

mmol/l

0.17

110

620

Venous thromboembolism

246

1613

1.48

7.84

1.3

2.29

2.16

mmol/l

0.67

230

1487

Nonorganic sleeping disorders

118

673

1.76

7.82

1.3

1.71

1.93

mmol/l

3.66

108

626

Extracorporeal dialysis

155

2.67

7.81

1.3

2.00

mmol/l

0.01

148

Car occupant injured in other and unspecified transport accidents

108

601

1.81

7.78

1.2

1.3

1.97

1.92

mmol/l

0.22

102

561

Asthma (diagnoses ohter than nonallergic)

443

2755

1.34

7.74

1.3

1.2

2.03

2.05

mmol/l

0.08

406

2563

Disorders of sclera, cornea, iris and ciliary body

269

1865

1.45

7.74

1.2

1.3

2.05

2.06

mmol/l

0.02

254

1731

Other diseases of pleura

203

1161

1.54

7.73

1.3

2.17

2.20

mmol/l

0.10

188

1080

Pulmonary heart disease, diseases of pulmonary circulation

145

878

1.66

7.70

1.4

1.3

2.20

2.12

mmol/l

0.34

137

818

Assault

419

1.97

7.69

1.2

1.3

1.84

1.92

mmol/l

0.52

395

Diseases of pulp and periapical tissues and dental caries

330

1194

1.42

7.66

1.3

2.01

2.13

mmol/l

1.26

309

1114

Dentofacial anomalies [including malocclusion]

362

2119

1.37

7.58

1.2

1.3

1.88

2.00

mmol/l

1.53

333

1982

Dialysis, with operation codes

362

2.03

7.46

1.3

2.40

2.00

mmol/l

0.95

343

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

144

879

1.64

7.44

1.3

1.87

2.03

mmol/l

1.91

130

820

Parkinson's disease, strict definition

329

2.08

7.42

1.2

1.96

2.18

mmol/l

1.83

310

Other predominantly sexually transmitted diseases, not elsewhere classified

122

715

1.71

7.37

1.2

1.3

1.80

1.87

mmol/l

0.53

114

666

DVT of lower extremities and pulmonary embolism

186

1204

1.54

7.36

1.4

1.3

2.27

2.16

mmol/l

0.51

174

1114

Insomnia

445

2448

1.33

7.30

1.2

1.3

1.89

2.07

mmol/l

2.90

411

2272

Unspecified/other endometriosis

272

2.18

7.30

1.2

1.3

1.60

1.91

mmol/l

3.56

252

Diseases of the digestive system

213

1421

1.50

7.30

1.3

2.08

2.12

mmol/l

0.20

192

1314

Noninfectious colitis NAS

393

1.97

7.27

1.3

2.14

2.03

mmol/l

0.32

370

Urolithiasis

152

947

1.61

7.25

1.3

2.41

2.15

mmol/l

0.69

141

883

Fenamates

269

2.00

7.24

1.6

1.2

2.23

2.22

mmol/l

0.02

251

Other abnormal uterine and vaginal bleeding

117

480

1.75

7.24

1.6

1.3

2.33

2.12

mmol/l

0.90

109

441

Other disorders of bone

107

609

1.77

7.18

1.2

1.3

1.92

2.02

mmol/l

0.44

100

573

Other peripheral vertigo

225

2.28

7.03

1.3

1.87

2.16

mmol/l

1.86

212

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

470

2159

1.31

7.00

1.2

1.3

2.37

2.02

mmol/l

4.05

430

2003

Injuries to the neck

126

757

1.67

6.97

1.2

1.3

1.76

1.98

mmol/l

3.33

114

709

Early onset COPD, excluding more controls

428

1.90

6.90

1.4

1.2

2.14

2.20

mmol/l

0.17

406

Adverse effects, not elsewhere classified

109

632

1.73

6.88

1.3

1.74

1.96

mmol/l

3.00

102

592

Superficial injury of wrist and hand

110

640

1.73

6.86

1.2

1.3

1.78

1.94

mmol/l

1.29

103

602

Deforming dorsopathies

130

791

1.65

6.85

1.1

1.3

1.95

2.09

mmol/l

1.24

116

743

Nephropathy related operations

340

2.01

6.83

1.3

2.44

1.97

mmol/l

1.11

320

Insulin, fast-acting (human)

424

1.90

6.78

1.1

1.3

2.16

1.92

mmol/l

1.65

397

Sequelae of injuries, of poisoning and of other consequences of external causes

121

725

1.68

6.77

1.4

1.3

1.90

2.01

mmol/l

0.69

107

683

Benign neoplasm of other and unspecified endocrine glands

369

1.96

6.75

1.2

1.3

2.11

2.10

mmol/l

0.03

344

Persistent mood disorders

533

1.79

6.72

1.2

1.3

2.19

2.01

mmol/l

0.46

500

Diseases of male genital organs

248

860

1.46

6.72

1.2

1.99

2.10

mmol/l

0.92

230

794

Gout

116

605

1.69

6.63

1.2

1.3

2.28

2.19

mmol/l

0.34

110

558

Other disorders of patella

514

1.80

6.61

1.2

1.4

1.97

1.95

mmol/l

0.07

476

Asthma, including avohilmo

601

2681

1.26

6.47

1.2

1.3

1.98

2.07

mmol/l

0.94

555

2489

Other predominantly sexually transmitted diseases, not elsewhere classified

100

578

1.74

6.42

1.2

1.3

1.86

1.90

mmol/l

0.19

536

Compression of brain

+∞

6.40

1.8

0.0

1.83

—

mmol/l

—

Solid cancers, helper endpoint

401

1789

1.33

6.40

1.3

2.18

2.07

mmol/l

1.10

375

1659

Diseases of external ear

162

1057

1.54

6.39

1.2

1.3

1.99

2.06

mmol/l

0.31

150

995

Hyperosmolality and hypernatraemia

6.68

6.37

1.1

2.19

1.92

mmol/l

0.56

Open wound of wrist and hand

224

1528

1.44

6.30

1.2

1.3

1.93

2.05

mmol/l

1.15

201

1430

Conjunctivitis (acute, non atopic)

147

939

1.57

6.28

1.2

1.3

1.94

1.97

mmol/l

0.08

141

877

Meniscus derangement

259

1242

1.41

6.18

1.2

1.3

1.99

2.15

mmol/l

2.12

237

1149

Enthesopathies of lower limb, excluding foot

103

608

1.70

6.14

1.3

1.84

2.11

mmol/l

3.63

572

Fracture of foot, except ankle

125

777

1.62

6.11

1.3

1.96

1.95

mmol/l

0.06

113

731

Polymyalgia rheumatica

300

2.01

6.07

1.1

1.2

2.22

2.15

mmol/l

0.20

280

Calculus of kidney and ureter

138

880

1.57

6.06

1.3

2.46

2.12

mmol/l

0.90

128

820

Use of disulfiram, acamprosate or naltrexone

248

2.11

5.98

1.1

1.4

2.29

1.95

mmol/l

0.72

236

Mouth breathing

188

1283

1.47

5.97

1.2

1.3

1.88

2.07

mmol/l

2.63

175

1207

Diabetes, insulin treatment (Kela reimbursement)

485

2297

1.28

5.94

1.2

1.3

2.38

2.04

mmol/l

3.87

444

2128

Inflammatory diseases of prostate (prostatitis)

310

1.98

5.91

1.4

1.3

1.97

2.17

mmol/l

1.06

291

Rotator cuff syndrome

273

1421

1.38

5.91

1.2

1.3

1.94

2.24

mmol/l

6.70

253

1320

Chronic diseases of tonsils and adenoids

392

1893

1.31

5.90

1.2

1.3

1.88

2.07

mmol/l

2.94

357

1763

Diseases of peritoneum

263

2.07

5.88

1.4

1.3

2.12

2.09

mmol/l

0.07

247

Allergic asthma (mode), excluding more controls

100

580

1.69

5.87

1.4

1.2

1.80

1.91

mmol/l

0.76

544

Other diseases of anus and rectum

137

877

1.56

5.86

1.2

1.3

2.10

2.17

mmol/l

0.26

126

814

Obesity and other hyperalimentation

309

2220

1.34

5.86

1.1

1.3

2.10

2.01

mmol/l

0.50

287

2070

Pruritus

277

2.03

5.85

1.2

1.3

2.15

2.03

mmol/l

0.35

261

Lateral epicondylitis

332

1.94

5.84

1.3

1.5

1.87

2.11

mmol/l

2.08

310

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

11.45

5.84

2.2

1.4

2.96

1.81

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

299

2115

1.35

5.81

1.4

1.2

2.01

1.95

mmol/l

0.48

280

1966

Carpal tunnel syndrome

268

1724

1.37

5.78

1.2

1.3

2.12

2.14

mmol/l

0.09

254

1596

Acute and transient psychotic disorders

355

1.90

5.76

1.2

1.3

2.07

1.98

mmol/l

0.19

332

Alzheimer’s disease, strict definition

438

1.74

5.76

1.1

1.2

2.00

2.21

mmol/l

1.62

395

Allergic asthma (mode)

100

584

1.68

5.73

1.4

1.2

1.80

1.91

mmol/l

0.81

548

Acetic acid derivatives and related substances

128

410

1.62

5.73

1.2

2.06

2.19

mmol/l

0.40

120

377

Methotrexate

384

1.86

5.73

1.1

1.4

2.67

2.00

mmol/l

0.80

362

Restless leg syndrome

377

1.87

5.73

1.3

2.02

2.08

mmol/l

0.19

354

Monoplegia

5.68

5.72

1.4

1.2

1.80

1.82

mmol/l

0.03

Paroxysmal tachycardia

484

1.70

5.71

1.2

2.06

1.89

mmol/l

0.68

450

Vasomotor and allergic rhinitis

187

1264

1.46

5.70

1.2

1.3

1.83

1.99

mmol/l

1.41

174

1185

Drug-induced systemic lupus erythematosus

7.83

5.70

1.3

2.09

2.03

mmol/l

0.10

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

399

1.84

5.70

1.3

1.2

2.47

2.09

mmol/l

1.24

374

Diabetes mellitus

509

2358

1.26

5.69

1.2

1.3

2.26

1.99

mmol/l

5.81

461

2195

Propionic acid derivatives

140

444

1.59

5.69

1.4

1.2

1.93

2.13

mmol/l

1.50

129

411

Oter anti-inflammatory and antirheumatic agents, non-steroids

103

333

1.71

5.68

1.2

1.3

2.12

2.28

mmol/l

0.65

306

Gastroduodenal ulcer

108

658

1.64

5.68

1.3

2.21

2.19

mmol/l

0.07

610

Diabetic retinopathy

152

617

1.54

5.66

1.2

1.3

2.33

2.39

mmol/l

0.18

140

566

Other disorders of eyelid

187

1227

1.45

5.66

1.3

2.27

2.22

mmol/l

0.17

171

1136

Other diseases of stomach and duodenum

151

2.40

5.63

1.3

1.4

1.89

2.07

mmol/l

0.85

143

Obesity

306

2214

1.34

5.61

1.1

1.3

2.11

2.01

mmol/l

0.53

284

2065

Disorders of tooth development and eruption

416

1.74

5.59

1.3

1.2

1.82

1.96

mmol/l

1.08

397

Other and unspecified spinal muscular atrophies

10.29

5.57

1.3

1.0

1.87

1.77

mmol/l

—

Other arrhythmias

308

1739

1.34

5.54

1.2

1.3

2.01

2.06

mmol/l

0.35

276

1624

Trigeminal neuralgia

128

2.52

5.53

1.3

1.95

1.86

mmol/l

0.24

121

Dislocation, sprain and strain of joints and ligaments at neck level

491

1.74

5.53

1.1

1.3

1.74

1.94

mmol/l

2.05

459

Diabetes medication

512

2419

1.26

5.51

1.2

1.3

2.29

2.00

mmol/l

5.98

466

2249

Reimbursement for rheumatic diseases

263

1927

1.36

5.50

1.3

2.31

2.09

mmol/l

0.92

247

1782

Haemorrhage from respiratory passages

147

875

1.52

5.48

1.4

1.3

2.20

2.21

mmol/l

0.02

140

812

Congenital malformations, deformations and chromosomal abnormalities

323

2256

1.32

5.47

1.3

1.2

2.00

1.99

mmol/l

0.08

300

2097

Other and unspecified mood [affective] disorders

185

2.23

5.44

1.1

1.3

2.32

1.83

mmol/l

0.58

174

Other diseases of the digestive system

136

888

1.54

5.42

1.3

2.17

2.16

mmol/l

0.04

122

826

Wegener granulomatosis

5.71

5.40

1.0

1.2

1.95

2.01

mmol/l

0.09

Deviated nasal septum

152

1019

1.49

5.33

1.3

1.99

2.16

mmol/l

1.36

142

953

Tinnitus

107

665

1.62

5.29

1.2

1.3

1.87

2.09

mmol/l

2.02

632

Acute suppurative otitis media

146

912

1.50

5.16

1.3

2.01

1.84

mmol/l

0.68

136

845

Papulosquamous disorders

177

1233

1.44

5.15

1.2

1.3

2.10

2.06

mmol/l

0.12

162

1149

Benign neoplasm: Colon, unspecified

107

670

1.60

5.15

1.2

1.3

2.20

2.15

mmol/l

0.16

101

629

Other and unspecified injuries of head

164

2.27

5.14

1.2

1.3

2.05

1.99

mmol/l

0.10

155

Voice disturbances

122

789

1.55

5.11

1.2

1.3

2.01

2.06

mmol/l

0.15

116

733

Selective deficiency of immunoglobulin G [IgG] subclasses

8.62

5.11

1.6

1.3

1.75

1.94

mmol/l

—

Postzoster neuralgia

5.76

5.09

1.2

2.95

1.93

mmol/l

0.44

Diabetes, varying definitions

501

2358

1.25

5.08

1.2

1.3

2.27

1.99

mmol/l

5.99

455

2193

Cervicocranial syndrome

258

1.99

5.06

1.2

1.4

1.88

2.08

mmol/l

0.72

245

Injuries to the hip and thigh

203

1314

1.40

5.05

1.3

2.11

2.16

mmol/l

0.20

184

1222

Disorders of gallbladder, biliary tract and pancreas

464

2335

1.25

5.02

1.2

1.3

2.12

2.10

mmol/l

0.19

436

2163

Other enthesopathies

134

890

1.51

4.98

1.3

1.94

2.15

mmol/l

2.56

125

833

Fall on same level involving ice and snow

260

1943

1.34

4.97

1.2

1.3

2.06

2.08

mmol/l

0.11

237

1806

Anterior Iridocyclitis

614

1.62

4.97

1.2

1.3

2.19

2.01

mmol/l

0.79

577

Other (seronegative) rheumatoid arthritis, wide

507

1.68

4.97

1.2

1.4

2.27

2.10

mmol/l

0.61

479

Dislocation, sprain and strain of joints and ligaments of knee

295

2067

1.32

4.95

1.2

1.3

1.86

2.04

mmol/l

3.24

278

1914

Gout, FINNGEN

116

746

1.56

4.93

1.2

2.28

2.22

mmol/l

0.18

110

693

Gastric ulcer

433

1.74

4.93

1.4

1.3

2.15

mmol/l

0.01

404

Iridocyclitis

108

686

1.58

4.91

1.2

1.3

2.15

2.03

mmol/l

0.49

102

644

Crohn's disease of small intestine

201

2.11

4.86

1.3

2.04

1.95

mmol/l

0.17

191

Additional codes for the location of defect, injury or illness

143

2.33

4.85

1.2

1.4

1.65

1.98

mmol/l

3.26

135

Type 2 diabetes

471

2208

1.25

4.82

1.2

1.3

2.27

2.01

mmol/l

4.68

428

2054

Aspergillosis

9.23

4.81

1.2

1.1

1.96

1.76

mmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases

150

2.29

4.80

1.8

1.4

2.78

1.95

mmol/l

1.02

142

Superficial injury of thorax

437

1.72

4.79

1.2

1.3

2.10

2.05

mmol/l

0.09

407

Persons encountering health services for specific procedures, not carried out

209

2.07

4.78

1.1

1.3

1.93

2.03

mmol/l

0.28

198

Seborrhoeic dermatitis

250

1.97

4.77

1.8

1.3

2.02

2.00

mmol/l

0.05

235

Disorders of synovium and tendon

238

1544

1.35

4.76

1.2

1.3

1.92

2.15

mmol/l

3.52

223

1433

Other obstetric conditions, not elsewhere classified

176

783

1.43

4.72

1.3

1.2

1.77

1.76

mmol/l

0.01

166

727

Rheumatoid arthritis

135

813

1.49

4.71

1.2

1.3

2.20

2.15

mmol/l

0.21

121

750

Diabetic nephropathy

419

1.73

4.70

1.1

1.2

2.56

2.39

mmol/l

0.16

386

Corneal ulcer

577

1.62

4.69

1.3

2.08

2.01

mmol/l

0.18

540

Corticotropin deficiency

7.34

4.69

1.5

1.1

1.89

1.73

mmol/l

—

Soft tissue disorders related to use, overuse and pressure

116

759

1.53

4.65

1.3

2.25

2.16

mmol/l

0.13

103

711

Keratitis

165

1161

1.42

4.60

1.3

2.03

2.04

mmol/l

0.01

155

1087

Other diseases of hard tissues of teeth

272

1056

1.33

4.59

1.3

1.2

2.11

mmol/l

0.01

255

983

Drug-induced osteoporosis with pathological fracture

4.60

4.58

1.4

1.1

1.91

1.90

mmol/l

0.00

Occlusion and stenosis of arteries, not leading to stroke

8.29

4.57

1.9

1.1

2.46

1.97

mmol/l

—

Acute and subacute iridocyclitis

574

1.61

4.55

1.2

1.3

2.23

2.03

mmol/l

0.80

540

Suppurative and unspecified otitis media

189

1206

1.39

4.54

1.3

1.2

1.97

1.88

mmol/l

0.42

176

1124

Fissure and fistula of anal and rectal regions

111

725

1.54

4.50

1.2

1.3

2.02

2.08

mmol/l

0.17

101

684

Cholecystectomy

318

2134

1.29

4.50

1.2

1.3

2.15

2.13

mmol/l

0.11

301

1965

Inflammatory bowel disease

153

1067

1.44

4.49

1.2

1.3

1.95

1.97

mmol/l

0.14

146

998

Abnormal blood-pressure reading, without diagnosis

117

2.41

4.48

1.3

1.2

1.90

2.04

mmol/l

0.62

109

Other gastritis (incl. Duodenitis)

600

1.59

4.47

1.2

1.3

2.04

2.11

mmol/l

0.21

565

Persistent delusional disorders

188

2.09

4.45

1.3

2.50

2.01

mmol/l

0.60

176

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

443

2287

1.24

4.45

1.2

1.3

2.15

2.11

mmol/l

0.24

416

2112

GI-bleeding

130

880

1.48

4.45

1.3

2.20

2.17

mmol/l

0.12

116

817

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

172

770

1.42

4.45

1.3

1.2

1.77

1.76

mmol/l

0.07

162

715

Necrosis of pulp, including avohilmo

278

2129

1.30

4.44

1.2

1.3

1.98

2.06

mmol/l

0.59

255

1981

Wide developmental disorders, excluding more controls

2.95

4.43

1.2

1.3

1.49

1.76

mmol/l

1.08

Other fall from one level to another

111

728

1.53

4.42

2.0

1.2

2.09

1.96

mmol/l

0.55

104

680

Diseases of arteries, arterioles and capillaries

277

1563

1.31

4.41

1.2

1.3

2.27

2.18

mmol/l

0.64

256

1447

Otitis externa

107

697

1.54

4.41

1.1

1.3

2.00

2.01

mmol/l

0.03

655

Cholecystitis

359

1.76

4.38

1.2

1.3

2.14

2.16

mmol/l

0.10

334

Infective dermatitis

301

1.84

4.37

1.2

1.3

2.03

2.05

mmol/l

0.08

282

Bacterial pneumoniae

164

1024

1.41

4.35

1.5

1.3

2.15

2.05

mmol/l

0.38

140

957

Disorders of phosphorus metabolism and phosphatases

9.24

4.32

1.3

1.0

2.01

1.78

mmol/l

—

Other and unspecified disorders of binocular movement

9.18

4.31

1.1

1.3

1.69

1.67

mmol/l

—

5-aminosalicylic acid

638

1.56

4.29

1.3

1.96

1.95

mmol/l

0.01

601

Impingement syndrome of shoulder

105

686

1.54

4.28

1.4

1.3

2.16

2.22

mmol/l

0.26

642

Viral and other specified intestinal infections

106

677

1.53

4.28

1.4

1.3

1.92

1.87

mmol/l

0.26

101

632

Use of memantine

480

1.59

4.27

1.2

1.96

2.25

mmol/l

3.65

430

Use of other anti-dementia drugs

480

1.59

4.27

1.2

1.96

2.25

mmol/l

3.65

430

Phlebitis and thrombophlebitis (not including DVT)

100

647

1.55

4.26

1.2

1.3

2.31

2.05

mmol/l

0.99

611

Childhood asthma (age<16)

265

1.79

4.25

1.3

1.2

1.85

1.80

mmol/l

0.13

250

Acute laryngitis and tracheitis

342

1.76

4.24

1.1

1.3

1.96

1.84

mmol/l

0.46

321

Colonic or urogenital fistula

122

825

1.48

4.23

1.2

1.3

2.08

mmol/l

0.02

112

777

Endometriosis

166

687

1.42

4.22

1.3

1.2

2.06

2.01

mmol/l

0.15

155

638

Ulcer of lower limb, not elsewhere classified

356

1.75

4.22

1.2

1.3

2.57

2.15

mmol/l

1.04

336

Childhood asthma (age<16), excluding more controls

266

1.78

4.20

1.3

1.2

1.85

1.80

mmol/l

0.15

251

Diseases of oral cavity, salivary glands and jaws

271

1061

1.32

4.19

1.3

1.2

2.01

2.11

mmol/l

1.13

252

987

Benign neoplasm: Colon

222

1594

1.33

4.12

1.2

1.3

2.07

2.23

mmol/l

1.35

204

1480

Bacterial pneumonia, not elsewhere classified

154

960

1.42

4.12

1.5

1.3

2.08

2.06

mmol/l

0.06

132

897

Hand

8.27

4.10

1.1

1.3

1.74

1.69

mmol/l

—

Thyrotoxicosis, other and/or unspecified

582

1.57

4.10

1.5

1.3

2.24

2.01

mmol/l

1.07

546

Dermatophytosis

367

1.72

4.09

1.5

1.3

2.98

2.02

mmol/l

0.91

344

Bacterial pneumonia (organism specified)

185

1228

1.37

4.08

1.5

1.3

2.31

2.09

mmol/l

0.68

161

1139

Disorders of vitreous body and globe

210

1508

1.34

4.07

1.2

1.3

2.12

2.24

mmol/l

0.99

195

1401

Congenital hydrocephalus

10.41

4.05

1.3

1.75

1.55

mmol/l

—

Hyperplasia of prostate

147

580

1.44

4.05

1.1

1.2

1.99

2.20

mmol/l

1.74

135

536

Disorders of conjunctiva

396

2573

1.24

4.02

1.2

1.3

1.92

2.05

mmol/l

1.73

365

2388

Lesion of ulnar nerve

369

1.71

4.02

1.1

1.3

1.94

2.02

mmol/l

0.41

347

Superficial injury of forearm

281

1.82

4.00

1.3

1.4

2.12

1.91

mmol/l

0.35

261

Glucosamine medication

184

1075

1.37

4.00

1.3

2.35

2.28

mmol/l

0.19

170

990

Oxicams

101

370

1.55

3.99

1.2

1.3

1.93

2.23

mmol/l

2.38

340

Other coagulation defects

190

2.01

3.98

1.5

1.3

1.97

1.89

mmol/l

0.27

180

Other and unspecified psoriasis

170

2.07

3.96

1.2

1.3

1.89

2.03

mmol/l

0.57

160

Disturbance of activity and attention

380

1.68

3.88

1.1

1.3

1.62

1.72

mmol/l

1.26

355

Chronic gastritis

107

719

1.49

3.86

1.1

1.3

2.11

2.19

mmol/l

0.23

670

Viral and other specified intestinal infections

135

915

1.43

3.85

1.3

1.2

1.88

mmol/l

0.01

128

855

Other and unspecified local infections of skin and subcutaneous tissue

256

1.85

3.84

1.3

1.83

2.02

mmol/l

1.15

243

Arthrosis

317

1373

1.27

3.80

1.2

1.3

2.02

2.12

mmol/l

0.93

296

1266

Dyslexia and other symbolic dysfunctions, not elsewhere classified

12.43

3.79

1.2

1.6

1.98

1.89

mmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

129

444

1.46

3.77

1.3

1.2

1.89

2.13

mmol/l

1.97

121

411

Open wound of ankle and foot

294

1.78

3.77

1.3

1.79

1.94

mmol/l

0.95

277

Lagophthalmos

4.67

3.76

1.3

1.2

3.21

1.84

mmol/l

0.76

Disorders of vitreous body

203

1479

1.33

3.75

1.2

1.3

2.09

2.24

mmol/l

1.38

188

1373

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

134

947

1.42

3.73

1.3

2.05

1.96

mmol/l

0.27

129

889

Gout, idiopatic and unspecified

652

1.51

3.73

1.2

2.32

2.21

mmol/l

0.35

612

Nonsuppurative otitis media

117

696

1.46

3.71

1.1

1.3

2.22

1.85

mmol/l

1.23

112

645

Other/unspecified rheumatoid arthritis

303

1.76

3.71

1.3

2.39

2.18

mmol/l

0.62

283

Other skin changes

502

1.58

3.70

1.3

1.98

2.10

mmol/l

0.97

470

Spondylolisthesis/Spondylolysis

471

1.60

3.69

1.1

1.3

1.96

2.12

mmol/l

1.09

443

Amenorrhoea

210

1.92

3.67

1.1

1.3

1.82

1.89

mmol/l

0.23

194

Malignant melanoma, including Hilmo

433

1.62

3.66

1.3

2.07

2.14

mmol/l

0.30

409

Other local infections of skin and subcutaneous tissue

275

1.79

3.65

1.2

1.3

1.85

2.04

mmol/l

1.07

261

Statin medication

334

1501

1.25

3.64

1.2

1.3

2.06

2.05

mmol/l

0.03

306

1395

Presbycusis

258

1.81

3.64

1.1

1.2

2.36

2.14

mmol/l

0.32

235

Burns and corrosions

411

1.64

3.63

1.1

1.3

2.16

2.01

mmol/l

0.57

384

Dyshidrosis [pompholyx]

3.77

3.61

1.5

1.4

1.94

mmol/l

0.00

Benign neoplasm of colon, rectum, anus and anal canal

257

1746

1.28

3.58

1.2

1.3

2.03

2.21

mmol/l

1.89

236

1623

Tonsillectomy and adenotomy

284

1560

1.27

3.58

1.2

1.3

1.80

1.89

mmol/l

0.96

258

1459

Cervicobrachial syndrome

594

1.52

3.57

1.6

1.3

1.95

2.11

mmol/l

1.17

556

Generalized epilepsy, strict definition

3.07

3.54

1.4

1.2

1.75

1.76

mmol/l

0.01

Metabolic disorder, other/unspecified

10.46

3.54

1.0

1.7

1.68

1.46

mmol/l

—

Convergence insufficiency and excess

4.30

3.52

1.5

1.3

2.05

1.72

mmol/l

0.73

Flatulence and related conditions

6.25

3.51

1.1

1.2

1.88

1.62

mmol/l

—

Assault by bodily force

235

1.84

3.51

1.2

1.4

1.84

1.89

mmol/l

0.15

220

IBD patients in KELA-register

111

768

1.45

3.50

1.3

1.91

1.96

mmol/l

0.19

106

717

Spontaneous abortion

205

1049

1.32

3.48

1.2

1.94

2.02

mmol/l

0.39

192

975

Chondropathies

463

1.58

3.47

1.2

1.3

1.88

2.01

mmol/l

0.96

433

Agoraphobia

2.55

3.47

1.2

1.91

1.84

mmol/l

0.14

Fall on and from stairs and steps

114

795

1.44

3.45

1.3

2.08

2.05

mmol/l

0.08

103

748

Other abnormal products of conception

150

719

1.38

3.45

1.3

1.2

1.78

1.92

mmol/l

1.70

142

671

Other diseases of lip and oral mucosa

175

1312

1.34

3.43

1.3

2.01

2.07

mmol/l

0.23

154

1227

Cholelithiasis, broad definition with cholecystitis

389

2151

1.22

3.41

1.2

1.3

2.13

2.10

mmol/l

0.17

365

1990

Spondyloarthritis

513

1.54

3.39

1.3

2.13

1.97

mmol/l

0.58

481

Thyrotoxicosis

109

757

1.44

3.38

1.5

1.3

2.20

2.03

mmol/l

0.95

101

709

Narcolepsy and cataplexy

7.15

3.38

1.1

1.6

1.91

1.73

mmol/l

—

Anorexia (incl.atypical)

161

2.00

3.34

1.1

1.4

1.91

1.82

mmol/l

0.31

152

Localized swelling, mass and lump of skin and subcutaneous tissue

130

936

1.39

3.30

1.3

2.01

2.07

mmol/l

0.27

120

875

Vascular dementia (other)

8.74

3.28

1.3

1.0

2.30

2.11

mmol/l

—

Malignant melanoma

346

1.65

3.25

1.3

1.2

2.12

2.16

mmol/l

0.13

326

Dipeptidyl peptidase 4 (DPP-4) inhibitors

218

1355

1.29

3.25

1.2

1.3

2.52

2.12

mmol/l

3.75

196

1260

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

270

1707

1.25

3.19

1.3

1.2

2.04

2.01

mmol/l

0.14

258

1586

Seronegative rheumatoid arthritis

280

1.72

3.18

1.2

1.4

2.31

2.06

mmol/l

0.65

267

Biguanides

430

2189

1.20

3.16

1.2

1.3

2.33

2.05

mmol/l

2.61

392

2035

Inflammatory bowel disease, strict (require KELA)

111

785

1.42

3.15

1.3

1.91

1.96

mmol/l

0.19

106

732

DVT of lower extremities

491

1.53

3.14

1.2

1.3

2.29

2.09

mmol/l

0.61

462

Fibroblastic disorders

604

1.48

3.14

1.2

1.4

2.15

2.28

mmol/l

0.46

565

Foreign body in genitourinary tract

4.58

3.13

1.2

1.4

1.98

1.92

mmol/l

—

Injury of nerves at shoulder and upper arm level

4.07

3.10

1.2

1.80

2.00

mmol/l

—

Hypertensive encephalopathy

7.77

3.08

1.3

1.1

1.80

1.88

mmol/l

—

Other cataract

173

992

1.32

3.08

1.3

2.16

2.23

mmol/l

0.35

163

921

Other disorders of peripheral nervous system

7.66

3.07

1.0

1.4

1.97

2.00

mmol/l

—

Malignant neoplasm of nasal cavity and sinuses

7.65

3.07

1.0

1.1

4.20

1.72

mmol/l

—

Folate deficiency anaemia

5.09

3.07

1.0

1.1

1.93

1.84

mmol/l

—

Failed induction of labour

195

1.86

3.06

1.1

1.3

1.66

1.70

mmol/l

0.22

182

Disorders of pituitary gland, other and/or unspecified

5.99

3.04

1.4

1.1

2.16

1.76

mmol/l

—

Asthma, hospital admissions , main diagnosis only

377

2770

1.20

3.03

1.3

1.2

1.96

2.05

mmol/l

0.75

342

2577

Other specified and unspecified personality disorders

285

1.69

3.01

1.2

1.4

1.92

1.99

mmol/l

0.20

268

Psoriasis

122

885

1.38

3.01

1.2

1.3

2.09

2.05

mmol/l

0.11

113

833

Senile degeneration of the brain, not elsewhere classified

10.27

3.00

1.2

1.0

1.77

1.95

mmol/l

—

Syndrome of inappropriate secretion of antidiuretic hormone

10.22

2.99

1.6

1.2

2.16

1.93

mmol/l

—

Hyperkinetic disorders

424

1.55

2.98

1.1

1.3

1.61

1.73

mmol/l

1.45

394

Trochanteric bursitis

347

1.62

2.98

1.3

1.4

1.95

2.13

mmol/l

1.33

322

Injuries to the elbow and forearm

314

2263

1.22

2.98

1.2

1.3

2.06

2.05

mmol/l

0.04

283

2104

Cholelithiasis

369

2112

1.21

2.98

1.2

1.3

2.13

2.10

mmol/l

0.20

346

1952

Phobic anxiety disorders

386

1.58

2.96

1.2

1.80

1.88

mmol/l

0.47

361

Maternal care for other conditions predominantly related to pregnancy

101

698

1.42

2.94

1.1

1.3

1.89

1.86

mmol/l

0.10

652

Malignant neoplasm of skin

187

987

1.30

2.93

1.2

1.3

2.15

2.18

mmol/l

0.18

169

917

4.78

2.93

1.1

1.80

1.68

mmol/l

—

Non-ischemic cardiomyopathy

123

719

1.38

2.93

1.5

1.3

2.10

2.22

mmol/l

0.82

118

671

Heart failure,strict

207

1141

1.28

2.92

1.4

1.3

2.21

2.20

mmol/l

0.05

194

1059

Conjunctivitis

352

2443

1.20

2.90

1.3

1.93

2.03

mmol/l

0.97

326

2272

Ganglion

615

1.45

2.89

1.2

1.4

1.87

2.06

mmol/l

2.11

575

Atrial fibrillation and flutter

111

512

1.41

2.89

1.1

2.32

1.95

mmol/l

1.25

102

482

Valgus deformity, not elsewhere classified

5.48

2.88

1.0

1.5

1.58

1.61

mmol/l

—

Postdysenteric arthropathy

5.47

2.88

1.1

1.3

5.59

1.72

mmol/l

—

Obsessive-compulsive disorder

178

1.86

2.86

1.1

1.2

1.72

1.84

mmol/l

0.43

167

Diseases of salivary glands

138

1030

1.34

2.86

1.2

1.3

1.88

2.04

mmol/l

1.58

129

960

Palmar fascial fibromatosis [Dupuytren]

359

1.59

2.85

1.1

1.2

2.28

2.41

mmol/l

0.31

336

Redundant prepuce, phimosis and paraphimosis

578

1.46

2.85

1.3

2.41

2.08

mmol/l

0.43

537

Other (not insulin) diabetes medications

434

2178

1.18

2.81

1.2

1.3

2.36

2.03

mmol/l

3.16

397

2023

Other disorders of thyroid

3.62

2.79

1.5

1.3

2.29

1.94

mmol/l

—

Allergic rhinitis

148

1108

1.32

2.78

1.2

1.3

1.77

1.91

mmol/l

1.68

139

1034

Thyroiditis, ILD-related definition

308

1.63

2.75

1.5

1.4

2.01

1.96

mmol/l

0.18

289

Excessive earwax

224

1749

1.25

2.74

1.2

1.3

1.99

2.13

mmol/l

1.31

210

1615

Cutaneous lupus erythematosus

2.73

2.72

1.2

1.3

1.78

1.95

mmol/l

0.67

Disorders of other and unspecified cranial nerves

6.15

2.72

1.5

1.2

1.59

1.88

mmol/l

—

Endometriosis of pelvic peritoneum

484

1.48

2.71

1.1

1.3

1.80

2.01

mmol/l

1.01

448

Disorder of thyroid, unspecified

3.80

2.68

1.1

1.3

2.04

1.98

mmol/l

—

Intestinal stricture

119

878

1.36

2.68

1.2

1.3

2.00

2.13

mmol/l

1.00

109

823

Other disorders of the musculoskeletal system and connective tissue

413

1.53

2.68

1.5

1.3

2.12

2.09

mmol/l

0.10

385

Noninflammatory disorders of female genital tract

194

761

1.28

2.62

1.2

1.91

1.97

mmol/l

0.32

183

707

Atopic dermatitis

269

1805

1.22

2.62

1.2

1.86

1.96

mmol/l

0.91

254

1685

Pustulosis palmaris et plantaris

100

2.11

2.59

1.1

1.2

1.98

1.94

mmol/l

0.09

Cushing syndrome

3.65

2.59

1.3

1.81

1.93

mmol/l

—

Biological medication for rheuma

564

1.44

2.58

1.2

1.3

2.39

1.95

mmol/l

0.58

527

Neuromyelitis optica

7.43

2.57

1.0

1.6

2.18

1.92

mmol/l

—

Moderate visual impairment, monocular

5.62

2.56

1.7

1.3

1.95

1.70

mmol/l

—

7.32

2.56

1.4

1.3

1.66

1.70

mmol/l

—

Unspecified protein-energy malnutrition

7.28

2.56

1.0

1.3

2.38

1.60

mmol/l

—

Kidney transplant status

142

1.91

2.56

1.2

1.3

1.83

1.98

mmol/l

0.50

135

Lesion of femoral nerve

5.54

2.55

1.0

1.4

1.55

1.73

mmol/l

—

Shock, not elsewhere classified

5.52

2.55

1.0

1.67

1.74

mmol/l

—

Fracture of shoulder and upper arm

143

1092

1.31

2.55

1.3

2.17

2.06

mmol/l

0.57

136

1013

Rheumatoid arthritis, including avohilmo

152

1172

1.30

2.55

1.2

1.3

2.20

2.07

mmol/l

0.78

138

1092

Vascular dementia (multiple infarctions)

7.18

2.55

2.0

1.1

2.00

1.81

mmol/l

—

Other overlap syndromes

3.00

2.49

1.8

1.4

1.80

1.97

mmol/l

0.86

Chronic rhinitis, nasopharyngitis and pharyngitis

132

1002

1.32

2.49

1.3

1.82

2.06

mmol/l

2.48

122

942

Atrial fibrillation and flutter with reimbursement

378

1.43

2.48

1.1

1.2

2.45

1.97

mmol/l

1.23

356

Artificial joint operation, meniscal resection

384

2116

1.18

2.47

1.2

1.3

2.10

2.17

mmol/l

0.31

351

1967

Dermatographic urticaria

180

1.79

2.47

1.3

1.4

1.71

1.91

mmol/l

1.60

169

Excessive attrition of teeth

250

2053

1.22

2.45

1.2

1.3

1.93

2.02

mmol/l

1.09

229

1913

Follicular cysts of skin and subcutaneous tissue

547

1.43

2.41

1.3

2.06

2.05

mmol/l

0.03

513

Chronic periodontitis, including avohilmo

427

2457

1.17

2.41

1.2

1.3

2.09

2.11

mmol/l

0.12

397

2270

Other acquired deformities of musculoskeletal system and connective tissue

117

1.98

2.40

1.5

1.3

1.89

2.01

mmol/l

0.36

111

Gonarthrosis [arthrosis of knee](FG)

312

1514

1.20

2.40

1.2

1.3

2.09

2.15

mmol/l

0.50

286

1408

Other acute viral hepatitis

3.38

2.40

1.0

1.4

1.81

1.75

mmol/l

—

Salpingitis and oophoritis

482

1.46

2.39

1.8

1.3

2.16

2.10

mmol/l

0.12

453

Ovarian cyst

158

706

1.29

2.38

1.2

1.82

2.00

mmol/l

2.43

147

653

Other/unspecified mastoiditis and related conditions

6.38

2.38

1.0

1.6

4.84

2.08

mmol/l

—

Other arthrosis

211

1177

1.24

2.38

1.2

1.3

2.19

2.16

mmol/l

0.14

199

1088

Ischemic heart diseases

356

1809

1.18

2.37

1.2

1.3

2.16

mmol/l

0.00

331

1681

Other drug-induced secondary parkinsonism

4.18

2.37

1.3

1.1

2.26

1.85

mmol/l

—

Other or ill-defined heart diseases

146

1.86

2.37

1.1

1.3

2.20

1.95

mmol/l

0.47

139

Retinal detachments and breaks

131

1002

1.31

2.36

1.3

2.23

2.19

mmol/l

0.10

121

930

Disease of hard tissues of teeth, NOS

242

1032

1.23

2.34

1.5

1.2

2.00

2.12

mmol/l

1.06

226

961

Coxarthrosis

191

1006

1.26

2.34

1.2

1.3

2.20

2.19

mmol/l

0.03

174

927

Pregnancy with abortive outcome

283

1225

1.21

2.30

1.4

1.2

1.91

2.04

mmol/l

1.45

260

1131

Postprocedural musculoskeletal disorders, not elsewhere classified

177

1.76

2.30

1.5

1.2

2.40

2.14

mmol/l

0.44

164

Paralytic ileus and intestinal obstruction

704

1.37

2.29

1.3

1.93

2.19

mmol/l

2.73

656

Coxarthrosis [arthrosis of hip](FG)

206

1171

1.24

2.28

1.2

1.3

2.19

mmol/l

0.01

187

1082

Drug-induced tremor

4.71

2.28

1.0

1.2

2.17

1.75

mmol/l

—

Dermatophytosis

261

2168

1.20

2.28

1.2

1.3

2.20

2.05

mmol/l

0.47

238

2021

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

4.67

2.28

1.0

1.1

4.20

1.72

mmol/l

—

False labour

143

689

1.30

2.25

1.2

1.3

1.73

1.89

mmol/l

2.21

136

636

Open wound of forearm

270

1.60

2.25

1.3

1.4

1.90

1.97

mmol/l

0.25

253

Gonarthrosis

261

1229

1.21

2.25

1.2

1.3

2.07

2.15

mmol/l

0.66

241

1138

Allergic urticaria

224

1.66

2.24

1.2

1.3

1.87

1.92

mmol/l

0.20

208

Hypothyroidism, autoimmune, DX-based

5.71

2.23

1.2

1.7

1.93

1.94

mmol/l

—

Toxic effect of organic solvents

5.71

2.23

1.0

1.4

2.44

2.07

mmol/l

—

Heart failure, strict

219

1260

1.23

2.23

1.4

1.3

2.24

2.22

mmol/l

0.07

206

1170

Glucagon-like peptide-1 (GLP-1) analogues

120

916

1.31

2.22

1.2

1.3

2.37

2.02

mmol/l

1.71

111

861

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

120

916

1.31

2.22

1.2

1.3

2.37

2.02

mmol/l

1.71

111

861

Wide developmental disorders

2.05

2.20

1.2

1.49

1.77

mmol/l

1.48

Other maternal disorders predominantly related to pregnancy

250

1296

1.21

2.19

1.3

1.88

2.02

mmol/l

2.14

236

1201

Hallux valgus (acquired)

129

712

1.30

2.19

1.2

1.3

2.29

2.11

mmol/l

0.59

116

659

Chronic hepatitis NAS

3.37

2.19

1.3

2.01

1.92

mmol/l

—

Benign neoplasm: Brain, unspecified

4.37

2.16

1.3

1.4

2.32

1.90

mmol/l

—

Periodontitis

425

2463

1.15

2.16

1.2

1.3

2.10

2.11

mmol/l

0.09

395

2276

Other disorders of optic disc

3.04

2.15

1.7

1.2

1.76

1.90

mmol/l

—

Disorders of breast

206

1528

1.23

2.15

1.2

1.3

1.97

2.07

mmol/l

0.68

187

1416

COPD (mode)

571

1.35

2.14

1.3

1.2

2.10

2.21

mmol/l

0.56

537

Fracture of lower leg, including ankle

227

1857

1.21

2.14

1.1

1.3

2.17

2.11

mmol/l

0.21

214

1714

Atopic dermatitis, strict definition with reimbursement

138

1042

1.28

2.13

1.3

1.87

1.86

mmol/l

0.01

131

978

All-cause Heart Failure

215

1243

1.22

2.12

1.4

1.3

2.25

2.23

mmol/l

0.08

203

1156

Fracture at wrist and hand level

146

1150

1.27

2.11

1.2

1.3

1.87

2.01

mmol/l

1.21

134

1080

Retinal vascular disorders

283

1.56

2.10

1.5

1.2

2.44

2.16

mmol/l

0.32

262

Drug-induced hypoglycaemia without coma

3.23

2.10

1.1

1.2

1.95

1.87

mmol/l

—

Haemorrhage in early pregnancy

122

917

1.30

2.09

1.2

1.3

1.86

1.96

mmol/l

0.71

114

853

Vascular diseases of the intestine

2.14

2.08

1.2

1.1

2.54

2.01

mmol/l

1.38

Acne conglobata

5.09

2.08

1.8

1.3

1.96

1.72

mmol/l

—

Hypertension, Pulmonary Arterial

5.06

2.08

1.4

2.16

1.79

mmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

133

1040

1.28

2.08

1.2

1.3

2.13

2.17

mmol/l

0.15

125

968

Iridocyclitis in diseases classified elsewhere

2.73

2.07

1.3

1.2

1.99

1.87

mmol/l

—

Urticaria due to cold and heat

4.05

2.05

1.0

1.3

1.68

1.86

mmol/l

—

Severe visual impairment, monocular

4.05

2.04

1.7

1.3

3.57

1.84

mmol/l

—

Type 2 diabetes, definitions combined

412

2099

1.15

2.04

1.2

1.3

2.31

2.03

mmol/l

4.20

375

1951

Melanoma in situ of trunk

3.11

2.02

1.0

1.2

1.81

1.80

mmol/l

—

Other otitis externa (chronic)

162

1.74

2.02

1.1

1.4

1.90

1.96

mmol/l

0.20

152

Simple and mucopurulent chronic bronchitis

2.06

2.01

1.4

1.2

2.28

2.04

mmol/l

0.51

Medical abortion

266

1210

1.19

1.99

1.4

1.2

1.99

2.05

mmol/l

0.32

242

1117

Retinal vascular occlusion

279

1.55

1.99

1.5

1.2

2.46

2.15

mmol/l

0.35

259

Hydrocele

279

1.55

1.99

1.2

2.04

2.22

mmol/l

0.64

260

Spondylopathies (FG)

418

1.44

1.98

1.4

1.3

2.15

1.95

mmol/l

0.53

393

Anoxic brain damage

3.36

1.97

1.6

1.0

2.17

1.84

mmol/l

—

Other congenital malformations of brain

4.64

1.95

1.2

1.6

1.72

1.54

mmol/l

—

Thrombotic microangiopathy

4.62

1.95

1.2

1.6

2.42

1.94

mmol/l

—

Transient synovitis

4.60

1.95

1.0

1.6

1.54

2.16

mmol/l

—

Other and unspecified primary disorders of muscles

3.81

1.94

1.0

1.3

1.90

1.69

mmol/l

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.81

1.94

1.8

1.2

2.45

1.86

mmol/l

—

Amoebiasis

3.80

1.94

1.2

1.4

2.15

1.86

mmol/l

—

Androgenic alopecia

3.80

1.94

1.7

1.2

2.02

1.85

mmol/l

—

Eosinophilia

2.99

1.94

1.5

1.3

1.93

1.82

mmol/l

—

Other disorders of conjunctiva

387

1.45

1.94

1.1

1.3

1.79

2.11

mmol/l

3.24

361

Other localized connective tissue disorders

2.75

1.93

1.6

1.3

2.48

2.01

mmol/l

—

Endometriosis ASRM stages 1,2

564

1.37

1.92

1.1

1.3

1.79

1.96

mmol/l

0.82

528

Effects of foreign body entering through natural orifice

102

781

1.31

1.90

1.2

1.3

2.11

2.00

mmol/l

0.40

732

Mantle cell lymphoma, including Hilmo

3.21

1.88

1.1

1.3

5.03

2.04

mmol/l

—

Schizophrenia

482

1.39

1.87

1.2

1.3

2.01

1.97

mmol/l

0.18

449

Coeliac disease

349

1.47

1.87

1.1

1.3

1.89

2.03

mmol/l

0.54

326

Benign neoplasm of urinary organs

107

1.88

1.86

1.2

1.70

2.02

mmol/l

1.62

101

Burn and corrosion of shoulder and upper limb, except wrist and hand

2.41

1.85

1.3

1.5

1.84

1.87

mmol/l

0.05

Acute mastoiditis

3.57

1.84

1.3

1.4

3.95

1.87

mmol/l

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.57

1.84

1.2

1.1

1.88

1.77

mmol/l

—

Alzheimer’s disease (Late onset)

391

1.40

1.84

1.2

1.1

2.13

2.22

mmol/l

0.37

351

Precocious central puberty

4.23

1.83

2.4

1.2

1.92

1.56

mmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

326

1.48

1.83

1.4

1.3

1.83

1.97

mmol/l

0.88

303

Perforation of tympanic membrane

278

1.52

1.81

1.2

1.3

2.03

mmol/l

0.00

261

Diaphragmatic hernia

135

1079

1.25

1.81

1.2

1.3

2.09

2.17

mmol/l

0.21

122

1002

Mature T/NK-cell lymphomas, hilmo

3.07

1.80

1.3

1.1

2.96

1.85

mmol/l

—

Ulcerative colitis

101

779

1.30

1.80

1.3

1.90

1.99

mmol/l

0.61

731

Type 2 diabetes, strict (exclude DM1)

411

2118

1.14

1.78

1.2

1.3

2.31

2.03

mmol/l

4.06

374

1970

Recurrent dislocation of patella

146

1.72

1.77

1.1

1.5

2.20

1.83

mmol/l

0.37

138

Mixed conductive and sensorineural hearing loss

304

1.48

1.77

1.3

2.48

2.14

mmol/l

0.41

286

Acute appendicitis, no complications

244

2063

1.18

1.76

1.2

1.3

1.83

2.04

mmol/l

4.44

226

1925

Hernia

409

2411

1.14

1.76

1.2

1.3

2.11

2.10

mmol/l

0.04

378

2233

Migraine, unspecified, drug-induced

3.90

1.72

1.4

1.82

1.89

mmol/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.90

1.72

1.4

1.2

2.08

1.82

mmol/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.88

1.72

1.4

1.5

2.06

1.77

mmol/l

—

Personal history of medical treatment

3.88

1.72

1.0

1.1

1.57

1.87

mmol/l

—

Atrophic disorders of skin

389

1.42

1.72

1.3

1.4

2.21

2.12

mmol/l

0.21

367

Cardiodefibrillation

1040

0.76

1.71

1.1

1.3

2.42

2.21

mmol/l

0.31

968

Follicular lymphoma, hilmo

1.89

1.71

1.1

1.2

2.01

2.02

mmol/l

0.00

Gingivitis and periodontal diseases

463

2118

1.13

1.70

1.2

1.3

1.94

2.09

mmol/l

3.33

426

1963

Atopic dermatitis, strict definition

133

1049

1.24

1.68

1.2

1.3

1.84

1.86

mmol/l

0.07

128

984

Varus deformity, not elsewhere classified

3.19

1.66

1.5

1.4

2.37

1.93

mmol/l

—

Monoarthritis, not elsewhere classified

1.86

1.66

1.1

1.5

2.14

2.02

mmol/l

0.17

Pollen allergy

675

1.30

1.66

1.2

1.3

1.69

1.84

mmol/l

1.75

624

Other/unspecified enthesopathies of lower limb, excluding foot

188

1.60

1.66

1.2

1.4

1.78

2.10

mmol/l

1.79

180

Other malignant neoplasms of skin (=non-melanoma skin cancer)

157

881

1.22

1.64

1.2

1.3

2.15

2.21

mmol/l

0.24

139

820

Female genital prolapse

117

522

1.27

1.63

1.2

2.04

2.11

mmol/l

0.32

107

482

Early onset COPD

616

1.32

1.63

1.4

1.3

2.14

2.12

mmol/l

0.08

580

Other and unspecified nonscarring hair loss

3.62

1.62

1.8

1.2

1.68

1.79

mmol/l

—

Fall involving playground equipment

3.62

1.62

1.2

1.5

1.72

1.65

mmol/l

—

Endometriosis ASRM stages 3,4

713

1.29

1.62

1.1

1.3

2.05

2.00

mmol/l

0.11

663

Squamous cell neoplasms and carcinomas of the skin

158

1.65

1.61

1.3

1.1

2.20

2.19

mmol/l

0.04

146

Type 2 diabetes, definitions combined, including avohilmo

410

2113

1.13

1.60

1.2

1.3

2.30

2.02

mmol/l

4.39

374

1964

Other benign neoplasms of skin

139

1133

1.23

1.60

1.2

1.3

2.06

2.10

mmol/l

0.14

129

1053

Other abnormal auditory perceptions

3.03

1.58

1.0

1.4

1.83

1.91

mmol/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.72

1.58

1.6

1.2

2.29

2.01

mmol/l

—

Other specified and unspecified strabismus

3.03

1.58

1.0

1.2

1.81

1.65

mmol/l

—

Non-allergic asthma (mode), excluding more controls

443

1.37

1.56

1.3

1.2

1.79

2.02

mmol/l

1.85

414

Autism spe, excluding more controls

2.28

1.55

1.0

1.1

1.53

1.83

mmol/l

—

Non-allergic asthma (mode)

444

1.36

1.55

1.3

1.2

1.79

2.01

mmol/l

1.81

414

Chronic periodontitis, complicated

214

1806

1.18

1.55

1.3

2.17

2.14

mmol/l

0.14

200

1683

Caries of enamel

403

2582

1.13

1.54

1.4

1.2

1.95

2.05

mmol/l

1.13

376

2399

Disturbances of smell and taste

1.93

1.54

1.1

1.5

2.55

2.18

mmol/l

0.18

Lichen planus

339

1.42

1.54

1.4

1.3

2.09

2.06

mmol/l

0.11

317

Helminthiases

2.44

1.54

1.3

1.2

1.96

1.80

mmol/l

—

Nail dystrophy

3.38

1.53

1.0

1.3

1.95

1.74

mmol/l

—

Cellulitis of external ear

2.88

1.51

1.2

1.5

1.78

1.89

mmol/l

—

Malignant neoplasm of heart, mediastinum and pleura

2.88

1.51

1.5

1.2

2.13

2.04

mmol/l

—

Coronary artery bypass grafting

559

0.73

1.50

1.2

2.46

2.22

mmol/l

0.46

523

Appendectomy

282

2350

1.15

1.50

1.2

1.3

1.91

2.06

mmol/l

1.95

262

2183

Hypertrophy of breast

529

1.33

1.50

1.3

1.4

2.04

2.01

mmol/l

0.06

493

Artrosis, including avohilmo

376

1820

1.13

1.49

1.1

1.3

1.97

2.10

mmol/l

1.56

352

1692

malignant neoplasm of male genital organs

468

1.28

1.49

1.3

1.2

2.21

2.15

mmol/l

0.18

437

Diverticular disease of intestine

272

1505

1.15

1.49

1.2

1.3

2.20

mmol/l

0.03

249

1397

Autism

2.01

1.49

1.0

1.3

1.49

1.69

mmol/l

0.78

449

1.34

1.48

1.2

2.11

2.26

mmol/l

0.79

409

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

165

933

1.20

1.46

1.2

1.3

2.27

2.20

mmol/l

0.19

148

869

Diseases of appendix

325

2583

1.13

1.46

1.2

1.3

1.90

2.08

mmol/l

2.44

298

2403

Open wound of lower leg

428

1.36

1.46

1.2

1.3

1.99

2.02

mmol/l

0.07

398

Respiratory disorders in diseases classified elsewhere

2.52

1.45

1.0

1.3

2.24

1.93

mmol/l

—

Thyrotoxicosis with diffuse goitre

394

1.37

1.45

1.4

1.3

2.02

2.00

mmol/l

0.07

370

Non-rheumatic valve diseases

176

1067

1.19

1.45

1.4

1.3

2.23

2.14

mmol/l

0.39

161

993

Systemic sclerosis,strict definition

3.16

1.44

1.0

1.3

3.08

1.76

mmol/l

—

Hypertrophy of (infrapatellar) fat pad

3.15

1.44

1.6

1.4

1.56

2.06

mmol/l

—

Malignant neoplasm of lip, including Hilmo

3.15

1.44

1.0

1.3

2.06

2.20

mmol/l

—

Evidence of alcohol involvement determined by level of intoxication

2.75

1.44

1.2

1.3

3.63

1.87

mmol/l

—

Contracture of joint

2.75

1.44

1.5

1.2

1.48

1.97

mmol/l

—

Varicose veins

232

1509

1.16

1.43

1.3

2.20

2.21

mmol/l

0.02

215

1392

Basal cell carcinoma

149

854

1.21

1.43

1.2

1.3

2.15

2.22

mmol/l

0.33

131

794

Myocardial infarction, strict

121

1055

0.82

1.43

1.1

1.3

2.29

2.18

mmol/l

0.32

110

986

Tumor necrosis factor alpha inhibitors

508

1.32

1.42

1.2

1.3

2.53

1.96

mmol/l

0.63

475

Valvular heart disease excluding rheumatic fever

178

1084

1.19

1.41

1.4

1.3

2.23

2.13

mmol/l

0.45

163

1008

Sulfasalazine

108

871

1.24

1.41

1.1

1.3

2.37

2.02

mmol/l

0.64

103

818

Labour and delivery complicated by umbilical cord complications

137

0.44

1.40

2.0

1.4

1.55

1.96

mmol/l

—

127

Preterm labour and delivery

102

818

1.25

1.40

1.3

1.98

2.02

mmol/l

0.14

761

Scleritis

2.43

1.39

1.1

1.2

1.75

1.89

mmol/l

—

Malignant neoplasm of pancreas, including Hilmo

180

0.50

1.39

1.0

1.2

2.85

2.16

mmol/l

—

169

Other specified/unspecified hearing loss

206

1.51

1.37

1.3

1.2

2.25

2.09

mmol/l

0.18

195

Contact with venomous snakes and lizards

2.63

1.37

1.2

1.3

2.08

1.77

mmol/l

—

Cauda equina syndrome

2.63

1.37

1.0

1.2

1.70

1.83

mmol/l

—

Conduction disorders

112

736

1.24

1.37

1.2

1.3

2.21

2.12

mmol/l

0.41

102

690

Other and unspecified disorders of vitreous body

149

1229

1.20

1.36

1.2

1.3

2.03

2.24

mmol/l

1.97

139

1142

Liposarcoma, including Hilmo

2.97

1.36

1.2

1.89

2.07

mmol/l

—

Appendicitis, broad definition

321

2575

1.13

1.34

1.2

1.3

1.90

2.08

mmol/l

2.39

294

2396

Obstructed labour due to malposition and malpresentation of fetus

715

0.76

1.34

1.2

1.3

2.13

1.89

mmol/l

0.44

668

Infections of genitourinary tract in pregnancy

282

1.42

1.33

1.5

1.2

2.01

1.95

mmol/l

0.17

262

Malignant neoplasm of prostate

436

1.26

1.32

1.3

1.2

2.19

2.17

mmol/l

0.06

407

Malignant neoplasm of mesothelium and soft tissue

1.82

1.31

1.3

1.2

2.62

1.97

mmol/l

1.17

Disorders of globe

2.10

1.30

1.1

1.2

3.18

1.87

mmol/l

—

Examination and encounter for administrative purposes

1.76

1.29

1.1

2.25

1.96

mmol/l

0.45

Major coronary heart disease event

343

1844

1.12

1.28

1.2

1.3

2.16

2.17

mmol/l

0.06

319

1713

132

1008

1.20

1.27

1.2

1.3

2.11

2.27

mmol/l

0.94

114

935

Coronary revascularization (ANGIO or CABG)

319

1735

1.13

1.25

1.2

1.3

2.18

2.17

mmol/l

0.07

297

1610

Placenta praevia

158

0.50

1.25

1.1

1.4

1.86

1.75

mmol/l

—

147

Other inflammation of eyelid

372

1.35

1.23

1.2

1.82

2.04

mmol/l

1.26

351

Impacted teeth

628

1.25

1.22

1.5

1.3

1.86

1.75

mmol/l

0.49

588

Fracture of femur

600

1.26

1.22

1.3

1.2

2.22

2.18

mmol/l

0.09

558

Disorder of the sleep-wake schedule

2.18

1.21

1.0

1.4

1.63

1.80

mmol/l

—

Benign lipomatous neoplasm

109

898

1.22

1.21

1.2

1.3

2.29

2.09

mmol/l

0.60

100

846

Malignant neoplasm of pancreas

143

0.49

1.20

1.0

1.2

2.96

2.03

mmol/l

—

134

Lichen planus, including avohilmo

505

1.29

1.20

1.3

1.4

1.98

2.12

mmol/l

0.80

475

Drug-induced osteoporosis

2.32

1.19

1.0

1.2

1.95

1.90

mmol/l

—

AV-block

419

1.30

1.18

1.1

1.3

2.20

2.12

mmol/l

0.30

395

Abnormal serum enzyme levels

108

868

1.21

1.18

1.3

1.2

2.24

2.18

mmol/l

0.18

101

808

Blepharochalasis

810

1.22

1.18

1.3

2.33

2.21

mmol/l

0.26

758

Percutaneous Coronary Intervention

317

1734

1.12

1.18

1.2

1.3

2.20

2.17

mmol/l

0.13

295

1609

Hypertrophy of breast in women and men

613

1.26

1.17

1.4

1.3

2.05

2.02

mmol/l

0.09

570

Right hemicolectomy

127

0.47

1.16

1.2

1.3

2.34

2.07

mmol/l

—

119

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.00

1.16

0.0

1.3

—

1.82

—

Malignant neoplasm of cervix uteri

0.00

1.16

0.0

1.3

—

1.87

—

Ventral hernia

668

1.24

1.15

1.2

1.3

1.93

2.08

mmol/l

1.52

628

Malignant neoplasm of bone and articular cartilage

2.52

1.15

1.8

1.5

2.22

2.08

mmol/l

—

Glaucoma

198

1482

1.15

1.3

2.20

2.24

mmol/l

0.15

186

1369

Benign neoplasm of bone and articular cartilage

232

1.43

1.15

1.1

1.3

1.73

2.02

mmol/l

1.48

217

Ischaemic heart disease, wide definition

301

1666

1.12

1.11

1.2

1.3

2.20

2.18

mmol/l

0.12

277

1550

Benign neoplasm: Other parts of oropharynx

2.40

1.09

1.0

1.3

1.92

1.81

mmol/l

—

Other nonscarring hair loss

2.40

1.09

1.8

1.2

1.68

1.71

mmol/l

—

Localized scleroderma [morphea]

2.39

1.09

1.8

1.2

3.02

2.00

mmol/l

—

Anomalies of dental arch relationship, including avohilmo

590

1.24

1.09

1.4

1.3

1.76

1.91

mmol/l

1.00

544

Other disorders of breast

372

1.32

1.09

1.2

1.4

1.84

2.04

mmol/l

1.47

347

Malignant neoplasm of prostate, including Hilmo

457

1.22

1.07

1.3

1.2

2.17

2.15

mmol/l

0.05

426

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.66

1.06

1.2

1.5

1.75

1.77

mmol/l

0.03

Other disorders of pigmentation

1.66

1.06

1.0

1.2

1.61

1.97

mmol/l

2.32

Haemorrhoids and perianal venous thrombosis

113

946

1.19

1.06

1.3

2.10

2.21

mmol/l

0.31

106

880

Benign neoplasm: Stomach

236

1.40

1.06

1.2

1.92

2.14

mmol/l

0.90

221

Peritonsillar abscess

676

1.23

1.06

1.2

1.3

1.86

2.01

mmol/l

0.90

636

Acute appendicitis

297

2496

1.11

1.05

1.2

1.3

1.84

2.08

mmol/l

6.70

275

2323

Systemic sclerosis (FG)

1.97

1.03

1.0

1.3

2.51

2.03

mmol/l

—

Other and unspecified aplastic anaemias

2.29

1.03

1.0

1.5

1.69

1.87

mmol/l

—

Other chondrocalcinosis

2.29

1.03

1.0

1.1

1.66

2.01

mmol/l

—

Family history of other specific disorders

2.28

1.03

1.0

1.1

2.14

1.70

mmol/l

—

Use of cabergoline

2.28

1.03

2.8

1.3

1.54

1.76

mmol/l

—

Carcinoma in situ of skin of ear and external auricular canal

2.28

1.03

1.4

1.1

1.96

2.16

mmol/l

—

Basal cell carcinoma, including avohilmo

151

894

1.16

1.03

1.2

1.3

2.14

2.20

mmol/l

0.26

133

832

Maternal care for other known or suspected fetal problems

107

565

1.20

1.03

1.1

1.3

1.90

1.80

mmol/l

0.30

524

Injury of eye and orbit

411

1.29

1.02

1.2

1.3

1.78

1.98

mmol/l

2.40

387

Periapical abscess

175

1528

1.15

1.02

1.3

1.99

2.06

mmol/l

0.36

159

1424

Embedded and impacted teeth

118

823

1.18

1.02

1.5

1.3

1.90

1.79

mmol/l

0.46

108

772

Degenerative macular diseases

281

1.35

1.01

1.3

1.2

2.07

2.15

mmol/l

0.26

262

Impacted maxillary molar

188

1.44

1.01

1.2

1.4

1.74

1.75

mmol/l

0.04

174

Adenocarcinoma and papilloma adenocarcinoma of rectum

226

0.62

1.00

1.1

1.2

2.80

2.14

mmol/l

0.81

212

Combinations of oral blood glucose lowering drugs

818

1.20

1.00

1.3

2.46

2.09

mmol/l

2.28

771

Burns classified according to extent of body surface involved

2.19

0.98

1.8

1.2

2.08

1.79

mmol/l

—

Galactorrhea

2.19

0.98

1.0

1.3

1.97

1.87

mmol/l

—

Systemic sclerosis

1.81

0.96

1.0

1.3

2.51

2.09

mmol/l

—

Other disorders of veins

147

1267

1.15

0.96

1.2

1.3

2.04

2.11

mmol/l

0.27

138

1177

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

235

0.64

0.96

1.1

1.2

2.74

2.12

mmol/l

0.81

221

Lichen sclerosus et atrophicus

242

1.37

0.94

1.2

1.3

2.53

2.15

mmol/l

0.70

227

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

1.62

0.94

1.2

1.3

1.72

1.80

mmol/l

0.27

Benign mammary dysplasia

365

1.29

0.92

1.4

2.05

2.18

mmol/l

0.56

345

Abscess of external ear

2.16

0.91

1.0

1.3

3.85

1.87

mmol/l

—

Dermatitis due to ingested food

105

1.56

0.91

1.4

1.3

1.63

1.61

mmol/l

0.07

Gonarthrosis,primary

344

1934

1.10

0.90

1.3

2.09

2.21

mmol/l

1.38

308

1802

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

2.08

0.89

1.2

1.3

1.60

1.82

mmol/l

—

Malignant neoplasm of larynx, including Hilmo

2.08

0.89

2.3

1.1

3.15

2.05

mmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

622

1.21

0.85

1.3

1.98

2.11

mmol/l

0.86

582

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.67

0.85

1.3

1.5

1.53

2.11

mmol/l

1.80

Skin changes due to chronic exposure to nonionizing radiation

119

947

1.16

0.85

1.2

1.3

2.12

2.30

mmol/l

0.95

101

876

Clear cell adenocarcinoma of kidney

1.57

0.84

1.3

1.2

2.71

2.01

mmol/l

0.76

Seropositive rheumatoid arthritis

703

1.19

0.83

1.1

1.3

2.26

2.12

mmol/l

0.51

656

Contraceptive management

174

1081

1.13

0.83

1.3

1.95

2.00

mmol/l

0.20

161

1003

Myocardial infarction, without ST-elevation

127

1007

1.15

0.82

1.2

2.29

2.23

mmol/l

0.24

108

940

L02BA Anti-estrogens

444

0.76

0.82

1.1

1.4

2.09

2.13

mmol/l

0.09

422

Complications predominantly related to the puerperium

101

865

1.17

0.81

1.2

1.3

1.99

1.93

mmol/l

0.14

810

Hernia of abdominal wall

167

1484

1.13

0.80

1.2

1.3

2.03

2.11

mmol/l

0.36

156

1374

Glaucoma suspect

121

1053

1.15

0.79

1.2

1.3

2.12

2.17

mmol/l

0.21

113

977

Contact with other hot metals

1.83

0.79

1.3

1.2

2.46

1.85

mmol/l

—

Other mycoses, not elsewhere classified/unspecified

1.83

0.79

1.2

1.3

1.57

1.86

mmol/l

—

Actinic keratosis

115

923

1.15

0.79

1.2

1.3

2.14

2.30

mmol/l

0.81

854

Allergic contact dermatitis due to drugs in contact with skin

1.67

0.79

1.3

1.77

1.94

mmol/l

—

Asthma/COPD (KELA code 203)

412

2620

1.08

0.78

1.3

1.98

2.06

mmol/l

0.67

377

2435

Psoriasis vulgaris

565

1.21

0.78

1.2

1.3

1.89

2.02

mmol/l

0.98

531

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

225

1980

1.11

0.77

1.3

1.91

2.01

mmol/l

1.00

205

1842

Polypectomy (DHB20)

174

0.63

0.76

1.5

1.3

1.69

2.02

mmol/l

1.88

165

Stomatitis and related lesions

612

1.19

0.76

1.4

1.3

1.86

2.01

mmol/l

0.61

569

Lung cancer and mesothelioma

360

1.24

0.76

1.3

1.2

2.08

2.17

mmol/l

0.38

338

Systemic sclerosis, icd10

1.71

0.75

1.0

1.3

2.51

1.96

mmol/l

—

Personal history of allergy to drugs, medicaments and biological substances

2.10

0.74

1.2

1.1

1.54

1.74

mmol/l

—

Injury of nerves at forearm level

2.09

0.74

1.0

1.3

2.60

1.85

mmol/l

—

COPD, hospital admissions 1, only main diagnosis

815

0.85

0.74

1.3

2.13

2.25

mmol/l

0.60

757

Benign neoplasm of other and ill-defined parts of digestive system

486

1.22

0.74

1.1

1.3

2.16

2.09

mmol/l

0.17

458

Hallux rigidus

342

1.26

0.74

1.2

1.4

2.92

2.03

mmol/l

0.61

319

In situ neoplasms

132

1164

1.13

0.73

1.3

2.00

2.11

mmol/l

0.62

124

1072

Acne

333

1.26

0.73

1.6

1.3

1.95

1.76

mmol/l

0.76

307

Degeneration of macula and posterior pole

153

1082

1.13

0.73

1.3

2.12

2.25

mmol/l

1.05

142

996

Complications of labour and delivery

251

1271

1.10

0.73

1.3

2.00

2.01

mmol/l

0.09

234

1176

Emergency coronary revascularization (for ACS)

333

1868

1.08

0.73

1.2

1.3

2.17

2.18

mmol/l

0.01

309

1733

Leiomyoma of uterus

236

1217

1.10

0.71

1.3

2.11

2.08

mmol/l

0.15

219

1119

Shoulder region

1.93

0.71

1.0

1.1

1.48

1.86

mmol/l

—

Long labour

719

1.16

0.70

1.1

1.3

1.97

1.88

mmol/l

0.36

674

Pre-eclampsia or eclampsia

703

1.17

0.68

1.3

2.26

1.96

mmol/l

0.86

659

Abscess of lung

1.86

0.68

1.8

1.3

2.64

1.87

mmol/l

—

Other deformities of toe(s)

1.56

0.68

1.0

1.5

2.06

2.02

mmol/l

0.09

Guttate psoriasis

1.73

0.64

1.4

1.3

3.36

1.89

mmol/l

—

Ankylosing spondylitis, strict definition

129

0.62

0.64

1.6

1.4

2.90

1.90

mmol/l

—

121

Procreative management

133

991

1.12

0.62

1.2

1.3

1.92

1.94

mmol/l

0.10

121

917

Fracture of forearm

207

1735

1.09

0.62

1.2

1.3

2.10

2.05

mmol/l

0.22

189

1613

Unspecified maternal hypertension

1.67

0.61

1.0

2.1

1.80

1.79

mmol/l

—

Coxarthrosis, primary

200

1547

1.09

0.61

1.2

1.3

2.14

2.24

mmol/l

0.47

184

1435

Heart failure and bmi 25plus

117

700

1.13

0.61

1.3

2.24

2.28

mmol/l

0.10

108

651

Left ventricular outflow tract obstruction, narrow definition

137

0.66

0.60

1.7

1.4

2.60

1.96

mmol/l

—

130

Cholangitis (primary sclerosing, PSC)

139

1.37

0.60

1.1

1.3

2.07

2.03

mmol/l

0.09

133

Endometroid carcinoma of ovary, including Hilmo

0.00

0.60

0.0

1.0

—

1.93

—

Benign neoplasm: Rectum, anus and anal canal

536

1.18

0.60

1.2

1.3

1.85

2.15

mmol/l

4.30

504

Allergic conjunctivitis

234

2102

1.08

0.60

1.3

1.92

2.00

mmol/l

0.90

213

1957

Melanocytic naevi

110

977

1.13

0.59

1.1

1.3

2.04

1.99

mmol/l

0.11

918

Left bundle-branch block

192

1.30

0.59

1.3

1.2

2.02

2.01

mmol/l

0.03

180

Other appendicitis

228

1.27

0.58

1.5

1.3

2.53

2.04

mmol/l

0.40

216

Primary gonarthrosis, bilateral

170

1325

1.10

0.58

1.3

2.19

2.23

mmol/l

0.17

153

1235

Acne vulgaris

264

1.25

0.58

1.8

1.4

1.98

1.75

mmol/l

0.90

247

Malignant neoplasm of ovary

116

0.60

0.57

1.0

1.2

2.05

2.13

mmol/l

—

111

Malignant neoplasm of rectum

230

0.74

0.57

1.2

2.66

2.15

mmol/l

0.73

216

Alcohol-induced acute pancreatitis

1.45

0.55

1.0

1.4

1.93

2.02

mmol/l

0.30

Other pulmonary heart/vessel disease

1.45

0.55

1.5

1.2

1.96

2.01

mmol/l

0.10

Primary coxarthrosis, bilateral

776

1.13

0.54

1.2

1.3

2.14

2.20

mmol/l

0.25

720

Perineal laceration during delivery

530

0.85

0.54

1.1

1.2

1.73

1.78

mmol/l

0.26

499

Polyp of the female genital tract

112

574

1.12

0.53

1.1

1.2

1.85

2.07

mmol/l

2.44

105

531

Peroneal tendinitis

1.54

0.53

1.2

1.8

1.57

1.97

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

178

1349

1.09

0.53

1.3

2.14

2.21

mmol/l

0.30

163

1249

Speech therapy

791

0.87

0.52

1.1

1.3

2.13

2.09

mmol/l

0.10

745

Unspecified privation

296

1.22

0.51

2.1

1.3

1.96

2.03

mmol/l

0.16

279

Status post-ami

578

0.87

0.51

1.1

1.2

2.38

2.20

mmol/l

0.34

539

Conductive hearing loss, unspecified

225

0.75

0.50

1.3

2.16

2.06

mmol/l

0.20

215

Malignant neoplasm of breast, ER-positive, including Hilmo

106

733

1.12

0.50

1.2

1.3

2.11

2.16

mmol/l

0.21

676

Postmenopausal bleeding

415

1.13

0.49

1.6

1.3

2.19

mmol/l

0.02

384

Rheumatic fever incl heart disease

1.56

0.49

1.3

2.01

1.94

mmol/l

—

Foreign body on external eye

455

1.17

0.48

1.1

1.3

1.96

mmol/l

0.02

429

Postmenopausal atrophic vaginitis

435

0.87

0.48

1.3

2.11

2.18

mmol/l

0.28

402

Malignant neoplasm of breast, HER-positive

103

721

1.11

0.48

1.2

1.3

2.12

2.17

mmol/l

0.19

665

Obesity, other/unspecified

128

1167

1.10

0.46

1.1

1.3

1.96

1.94

mmol/l

0.07

121

1099

Female infertility

116

637

1.11

0.46

1.3

1.2

1.80

1.99

mmol/l

2.15

111

591

COPD, hospital admissions 3, with asthma pneumonia sepsis

592

1.13

0.45

1.4

1.2

2.12

2.23

mmol/l

0.49

551

L02BB Anti-androgens

209

0.76

0.45

1.6

1.1

2.55

2.15

mmol/l

0.65

192

Melanocytic naevi of trunk

366

1.18

0.45

1.1

1.3

2.12

2.04

mmol/l

0.11

340

Malignant neoplasm of rectum, including Hilmo

286

0.80

0.44

1.1

1.2

2.53

2.15

mmol/l

0.73

269

Injury of muscle and tendon at hip and thigh level

265

1.21

0.44

1.3

1.86

2.03

mmol/l

0.72

250

Pacemaker

820

1.11

0.44

1.2

1.3

2.05

2.26

mmol/l

1.69

759

Thyrotoxicosis with toxic multinodular goitre

139

1.30

0.43

1.4

1.3

2.52

2.14

mmol/l

0.61

133

HSIL lesion of the vagina

1.62

0.43

1.4

2.76

1.90

mmol/l

—

Other and unspecified haemorrhagic conditions

1.62

0.43

1.0

1.2

2.82

1.88

mmol/l

—

Adhesive middle ear disease

1.62

0.43

1.0

1.2

2.48

1.79

mmol/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.62

0.43

1.4

1.2

2.89

2.03

mmol/l

—

Benign neoplasm of breast

322

1.18

0.42

1.3

1.96

2.08

mmol/l

0.39

304

Spermatocele

176

1.25

0.41

1.4

1.2

2.02

2.13

mmol/l

0.37

166

Congenital malformations of oesophagus

0.00

0.41

0.0

1.9

—

1.85

—

Unstable angina pectoris

103

893

0.91

0.41

1.2

1.3

2.20

2.23

mmol/l

0.08

832

Abnormal findings on diagnostic imaging of breast

1.52

0.41

1.0

1.3

2.20

2.04

mmol/l

—

Anorexia

1.52

0.41

1.2

1.4

2.56

1.90

mmol/l

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.41

0.0

1.4

—

1.91

—

0.00

0.41

0.0

1.1

—

1.74

—

Villonodular synovitis (pigmented)

0.00

0.41

0.0

1.3

—

1.92

—

Other acquired deformities of ankle and foot

0.00

0.41

0.0

1.3

—

2.14

—

Caries in Clefts patients

0.00

0.41

0.0

1.3

—

1.86

—

Other noninflammatory disorders of uterus, except cervix

412

1.13

0.41

1.3

2.13

2.19

mmol/l

0.20

381

Gonarthrosis, primary, with knee surgery

190

1411

1.07

0.41

1.2

1.3

2.11

2.24

mmol/l

0.88

167

1314

Scarlet fever

0.00

0.41

0.0

1.3

—

1.64

—

Crystalline deposits in vitreous body

0.00

0.41

0.0

1.1

—

1.80

—

Multiple delivery

241

1.21

0.40

1.4

1.3

2.19

1.91

mmol/l

0.49

223

626

1.11

0.40

1.2

2.12

2.33

mmol/l

1.35

570

Vascular disorders of the intestines

150

1.27

0.40

1.2

1.3

2.45

2.08

mmol/l

1.07

140

Coronary atherosclerosis

235

1399

1.06

0.39

1.2

1.3

2.21

2.22

mmol/l

0.03

217

1302

CR(E)ST syndrome

1.39

0.38

1.0

1.3

2.44

1.91

mmol/l

—

Other menopausal disorders

505

0.90

0.37

1.3

1.2

1.96

2.12

mmol/l

0.81

466

Small cell lung cancer, helper endpoint

1.35

0.37

1.2

1.1

2.04

2.00

mmol/l

—

Impetigo

116

1.30

0.37

1.5

1.61

1.83

mmol/l

1.64

110

Hypertrophic disorders of skin

143

1.26

0.37

1.5

1.3

1.75

1.96

mmol/l

0.62

135

Fall on and from ladder

189

1.22

0.36

1.0

1.3

2.03

2.05

mmol/l

0.04

177

COPD, hospital admission 2, with asthma infections

736

1.10

0.36

1.3

2.14

2.24

mmol/l

0.40

687

Malignant neoplasm of breast, ER-negative, including Hilmo

555

1.12

0.35

1.2

1.4

2.39

2.18

mmol/l

0.46

515

Pre-eclampsia or poor fetal growth

115

1058

1.08

0.35

1.3

2.08

1.91

mmol/l

0.63

110

986

L02BG Aromatase inhibitors

830

1.10

0.35

1.4

1.3

2.17

2.23

mmol/l

0.23

764

Pure hyperglyceridaemia

1.40

0.35

1.5

1.2

1.83

1.91

mmol/l

—

Seborrhoeic keratosis

585

1.11

0.34

1.3

1.4

2.27

2.16

mmol/l

0.17

549

Umbilical hernia

844

1.09

0.33

1.3

2.11

2.05

mmol/l

0.14

787

Single spontaneous delivery

128

730

0.93

0.33

1.2

2.16

2.02

mmol/l

0.43

121

669

Malignant neoplasm of respiratory system and intrathoracic organs

416

1.12

0.33

1.2

2.39

2.19

mmol/l

0.53

392

Seropositive rheumatoid arthritis, wide

768

1.09

0.33

1.1

1.3

2.26

2.09

mmol/l

0.72

715

Event of undetermined intent

182

1.21

0.33

1.5

1.4

1.82

1.94

mmol/l

0.41

170

Gestational diabetes (for exclusion)

147

956

1.07

0.32

1.2

1.3

1.84

1.85

mmol/l

0.04

139

894

Malignant neoplasm of breast, HER-negative

503

1.11

0.31

1.2

1.4

2.42

2.19

mmol/l

0.45

466

Oesophageal varices

100

0.70

0.30

1.6

1.2

2.33

2.04

mmol/l

—

Erosion of teeth , including avohilmo

859

1.08

0.30

1.4

1.3

1.94

1.93

mmol/l

0.04

805

Hypertrophic scar

129

1.24

0.30

1.5

1.4

1.78

1.87

mmol/l

0.25

122

Oesophagitis

129

1.24

0.30

1.2

1.90

2.09

mmol/l

0.57

121

Ectopic pregnancy

514

1.11

0.30

1.1

1.3

1.84

2.07

mmol/l

1.53

478

Secondary right heart disease

1.34

0.30

1.3

1.2

2.03

mmol/l

—

Abrasion of teeth

121

1131

1.07

0.29

1.3

2.04

2.07

mmol/l

0.09

108

1054

Congenital malformations of aortic and mitral valves

110

0.73

0.29

1.8

1.2

2.71

1.99

mmol/l

—

103

Other/unspecified seropositive rheumatoid arthritis

756

1.09

0.28

1.1

1.3

2.26

2.09

mmol/l

0.71

703

Normotensive glaucoma

195

1.18

0.28

1.3

1.2

1.87

2.18

mmol/l

1.54

183

Peripheral artery disease

131

980

1.06

0.27

1.3

2.40

2.23

mmol/l

0.91

120

908

Malignant neoplasm of ovary, including Hilmo

150

0.80

0.27

1.0

1.2

2.02

2.14

mmol/l

0.19

142

Macular hole

128

0.78

0.26

1.0

1.2

1.76

2.07

mmol/l

—

119

Other hammer toe(s) (acquired)

399

1.11

0.26

1.2

1.3

2.08

2.15

mmol/l

0.17

367

Sulfonylureas

727

1.07

0.26

1.1

1.2

2.54

2.14

mmol/l

1.59

673

Unspecified jaundice

1.26

0.26

1.0

1.2

3.17

2.07

mmol/l

0.85

Presence of cardiac and vascular implants and grafts

129

903

1.06

0.25

1.2

1.3

2.29

2.24

mmol/l

0.13

115

840

Ectropion of eyelid

1.25

0.25

1.2

1.1

2.33

2.03

mmol/l

—

Embolic stroke

1.23

0.25

1.0

1.2

2.34

2.08

mmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

190

1369

1.05

0.25

1.3

2.06

1.98

mmol/l

0.29

184

1267

Sequelae of injuries of lower limb

266

0.86

0.24

1.0

1.3

1.86

2.02

mmol/l

0.70

252

COPD related to multimorbidity

118

938

1.06

0.24

1.3

1.2

2.18

2.27

mmol/l

0.41

108

873

All dysplastic lesions of the cervix uteri, vagina or vulva

107

991

1.06

0.24

1.3

2.17

1.88

mmol/l

0.89

102

925

Calcific aortic valvular stenosis, diagnosis (helper)

712

0.93

0.23

1.2

2.46

2.26

mmol/l

0.37

656

Operations 2 for CAVS

712

0.93

0.23

1.2

2.46

2.26

mmol/l

0.37

656

Calcific aortic valvular stenosis, operated

712

0.93

0.23

1.2

2.46

2.26

mmol/l

0.37

656

Calcific aortic valvular stenosis

712

0.93

0.23

1.2

2.46

2.26

mmol/l

0.37

656

Other specified/unspecified deforming dorsopathies

1.32

0.23

2.0

1.2

2.04

2.02

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

171

1.17

0.23

1.3

1.2

2.59

2.03

mmol/l

0.95

163

Inguinal hernia

219

1405

1.04

0.22

1.2

1.3

2.11

2.12

mmol/l

0.04

203

1311

Laparoscopic right hemicolectomy

125

1.20

0.22

1.1

1.2

1.93

2.04

mmol/l

0.46

116

Polycystic ovarian syndrome

172

1.16

0.22

1.2

1.3

1.60

1.74

mmol/l

0.82

158

Benign neoplasm: Mediastinum

0.00

0.21

0.0

1.2

—

1.95

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.2

—

1.60

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.2

—

1.89

—

Down's syndrome

0.00

0.21

0.0

2.0

—

1.68

—

Chronic thyroiditis

0.00

0.21

0.0

1.5

—

2.07

—

Hypospadias

0.00

0.21

0.0

1.2

—

1.77

—

Other congenital malformations of kidney

0.00

0.21

0.0

1.3

—

1.66

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.21

0.0

1.2

—

1.80

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.4

—

1.94

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.1

—

1.83

—

Carcinoma in situ of vagina

0.00

0.21

0.0

1.5

—

1.96

—

Familial erythrocytosis

0.00

0.21

0.0

1.2

—

1.69

—

Other specified/unspecified diseases of inner ear

0.00

0.21

0.0

1.2

—

1.77

—

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.4

—

1.79

—

Abnormality of red blood cells

0.00

0.21

0.0

1.2

—

1.73

—

Felty syndrome

0.00

0.21

0.0

1.2

—

2.06

—

Carcinoma in situ of breast

0.00

0.21

0.0

1.0

—

1.92

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.4

—

1.71

—

Gangrene, not elsewhere classified

0.00

0.21

0.0

1.1

—

1.89

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.21

0.0

1.4

—

1.80

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

1.5

—

1.76

—

Endometroid carcinoma of ovary

0.00

0.21

0.0

1.1

—

1.91

—

Deformity of finger(s)

0.00

0.21

0.0

1.2

—

1.98

—

Pediculosis and phthiriasis

0.00

0.21

0.0

1.4

—

1.96

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.21

0.0

1.1

—

1.79

—

Lymphangioma, anys site

0.00

0.21

0.0

1.7

—

1.78

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

126

1.19

0.21

1.3

1.4

2.34

2.17

mmol/l

0.12

118

Mucinous and mucinous cystic tumor

0.00

0.21

0.0

1.2

—

1.95

—

Benign neoplasm: Endocrine pancreas

0.00

0.21

0.0

1.2

—

1.74

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.21

0.0

1.4

—

2.01

—

Birth trauma

0.00

0.21

0.0

2.1

—

1.84

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.1

—

1.72

—

Scarlet fever

0.00

0.21

0.0

1.3

—

1.69

—

Malignant neoplasm of breast, HER2-negative

136

847

1.05

0.20

1.2

1.3

2.25

2.13

mmol/l

0.49

124

784

Right side

0.00

0.20

0.0

1.1

—

1.89

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.20

0.0

1.1

—

1.98

—

Mucinous and mucinous cystic tumor, including Hilmo

0.00

0.20

0.0

1.4

—

1.93

—

Congenital vesicoureteral reflux

0.00

0.20

0.0

1.6

—

1.82

—

Carcinoma in situ of breast, lobular

0.00

0.20

0.0

1.0

—

1.96

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.20

0.0

1.3

—

1.91

—

Other mosquito-borne viral fevers

0.00

0.20

0.0

1.4

—

1.89

—

Bullous keratopathy

0.00

0.20

0.0

1.1

—

1.94

—

Xanthelasma of eyelid

0.00

0.20

0.0

1.2

—

1.79

—

Inflammatory disorders of breast

183

1.15

0.20

1.1

1.3

1.80

1.93

mmol/l

0.45

171

Atherosclerosis, excluding cerebral and coronary sclerosis

119

895

1.05

0.20

1.3

1.2

2.40

2.25

mmol/l

0.70

110

829

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.23

0.20

1.0

1.2

2.23

1.94

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

384

1.09

0.19

1.1

1.3

1.88

2.08

mmol/l

1.23

362

Calcific aortic valvular stenosis, including rheumatic fever

714

0.94

0.19

1.2

2.45

2.26

mmol/l

0.35

658

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

753

1.06

0.19

1.1

1.3

2.28

2.09

mmol/l

0.77

700

Benign neoplasm: Ascending colon

356

1.10

0.19

1.2

1.3

1.94

2.16

mmol/l

1.01

334

Malignant neoplasm of breast

138

860

1.05

0.19

1.2

1.3

2.25

2.14

mmol/l

0.43

125

797

Psoriasis (vulgaris), strict definition

1.24

0.18

1.1

1.3

2.03

1.94

mmol/l

—

Pericarditis

1.21

0.17

1.1

1.4

1.74

1.88

mmol/l

0.65

Crossbite

189

1.13

0.17

1.2

1.4

1.49

1.82

mmol/l

4.27

178

Other specified disorders of kidney and ureter

1.13

0.16

1.1

1.2

2.41

2.01

mmol/l

—

Persons encountering health services in circumstances related to reproduction

214

1486

0.97

0.16

1.4

1.3

1.94

2.01

mmol/l

0.35

200

1375

Benign neoplasm: Descending colon

168

1.13

0.15

1.1

1.2

2.10

2.07

mmol/l

0.06

157

Dronedarone medication

0.78

0.15

1.2

2.37

1.86

mmol/l

—

Medical treatment for female infertility

755

0.95

0.15

1.3

1.2

1.79

1.85

mmol/l

0.35

707

Erectile dysfunction

197

1.12

0.15

1.3

1.2

2.16

2.05

mmol/l

0.36

182

Nonischemic cardiomyopathy

264

1.10

0.15

1.2

1.3

2.31

2.06

mmol/l

0.44

253

1.12

0.15

1.4

1.3

1.48

1.51

mmol/l

—

Heart failure and coronary heart disease

124

913

0.96

0.14

1.2

2.34

2.23

mmol/l

0.32

113

850

Pregnancy hypertension

153

1325

1.03

0.14

1.2

1.3

2.20

1.97

mmol/l

1.03

142

1236

Labour and delivery complicated by fetal stress [distress]

610

0.95

0.14

1.2

1.82

1.77

mmol/l

0.29

570

Malignant neoplasm of bronchus and lung

365

0.93

0.14

1.2

2.11

2.18

mmol/l

0.23

342

Rubella [German measles]

1.19

0.14

1.2

1.4

1.90

2.02

mmol/l

—

Bicuspidal aortic valve syndrome

0.82

0.13

1.8

1.2

2.71

2.02

mmol/l

—

Maternal care for known or suspected abnormality of pelvic organs

619

0.96

0.13

1.2

1.3

1.80

1.91

mmol/l

0.95

577

Angina pectoris

183

1255

0.97

0.13

1.2

1.3

2.19

2.21

mmol/l

0.05

166

1166

Coxarthrosis, primary, with hip surgery

142

1286

1.03

0.13

1.2

1.3

2.16

2.27

mmol/l

0.42

134

1188

Ulcerative ileocolitis

108

0.83

0.13

1.1

1.5

2.07

1.90

mmol/l

—

101

COPD, hospital admissions

129

1128

0.97

0.13

1.3

2.12

2.23

mmol/l

0.65

119

1047

Foreign body or object entering through skin

181

1.11

0.12

1.3

1.4

1.72

2.00

mmol/l

1.91

171

Gestational [pregnancy-induced] hypertension

892

0.96

0.11

1.2

1.3

2.00

1.91

mmol/l

0.26

840

Adjustment and management of implanted device

415

1.06

0.11

1.1

1.2

1.96

2.18

mmol/l

1.09

386

Embedded teeth, including avohilmo

308

1.07

0.11

1.3

1.95

1.81

mmol/l

0.16

285

Single delivery by caesarean section

373

0.95

0.11

1.7

1.2

1.87

1.86

mmol/l

0.04

344

COPD

138

1097

1.03

0.10

1.3

2.14

2.20

mmol/l

0.37

127

1023

Malignant neoplasm of bladder

125

0.88

0.10

1.1

2.58

2.13

mmol/l

0.38

113

Exclusion endpoint for clefts

1.11

0.09

1.2

1.3

1.58

1.77

mmol/l

—

Delivery

135

732

0.97

0.09

1.5

1.2

2.19

2.02

mmol/l

0.57

126

671

COPD, early/later onset

131

1133

0.97

0.09

1.3

2.15

2.23

mmol/l

0.41

121

1050

Malignant neoplasm of oesophagus, including Hilmo

0.86

0.07

1.0

1.1

1.86

2.01

mmol/l

—

Tooth eruption problems

497

1.04

0.07

1.2

1.3

1.82

1.74

mmol/l

0.14

462

Polycythaemia vera

0.80

0.07

1.5

1.3

2.10

2.03

mmol/l

—

Carcinoma in situ, bladder

1.08

0.07

1.3

1.1

2.27

2.05

mmol/l

—

Lesion of sciatic nerve

1.07

0.07

1.5

1.2

1.83

1.98

mmol/l

—

Carcinoma in situ of other and unspecified sites

1.04

0.07

1.3

1.1

2.27

2.05

mmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

138

875

1.02

0.07

1.1

1.3

2.21

2.13

mmol/l

0.26

124

810

Pregnancy, childbirth and the puerperium

504

0.97

0.07

1.5

1.2

2.05

1.93

mmol/l

0.53

456

Malignant neoplasm of breast, including Hilmo

138

875

1.02

0.07

1.1

1.3

2.21

2.13

mmol/l

0.26

124

810

Use of ropinirole

1.03

0.07

1.1

1.2

2.00

1.96

mmol/l

—

Benign neoplasm: Rectosigmoid junction

1.03

0.07

1.1

1.71

2.01

mmol/l

—

Cardiomyopathy, other and unspecified

216

1.07

0.06

1.1

1.3

2.33

1.99

mmol/l

0.50

206

Malignant neoplasm of bronchus and lung, including Hilmo

442

0.97

0.06

1.2

2.04

2.20

mmol/l

0.83

413

Myocardial infarction

155

1109

0.98

0.06

1.2

1.3

2.30

2.18

mmol/l

0.46

140

1033

Injury of muscle and tendon at lower leg level

436

0.96

0.06

1.2

1.3

2.12

2.05

mmol/l

0.19

411

Biomechanical lesions, not elsewhere classified

121

0.91

0.06

1.2

1.4

1.77

2.03

mmol/l

2.02

114

Other chronic obstructive pulmonary disease

131

1060

1.02

0.05

1.3

2.15

2.21

mmol/l

0.31

121

988

Medicines for HER+ breast cancer

108

1003

1.02

0.05

1.3

2.12

2.19

mmol/l

0.33

924

Other diseases of biliary tract

218

1.06

0.05

1.0

1.3

2.33

2.11

mmol/l

0.44

207

Other osteochondropathies

199

1.06

0.04

1.3

1.4

1.98

mmol/l

0.00

187

Carbimazole or st.post thyroidectomy, condition for graves disease

635

0.98

0.04

1.4

1.3

2.06

2.02

mmol/l

0.12

596

Major coronary heart disease event excluding revascularizations

201

1352

0.99

0.03

1.2

1.3

2.25

2.23

mmol/l

0.08

182

1257

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

166

1429

1.01

0.03

1.2

1.3

2.17

1.98

mmol/l

0.83

154

1330

Other and/or unspecified nontoxic goitre

189

0.95

0.03

1.3

2.03

2.17

mmol/l

0.24

176

Diabetes mellitus in pregnancy

123

778

1.01

0.03

1.2

1.84

mmol/l

0.02

117

722

Myocardial infarction, unclassifiable

472

1.02

0.03

1.1

1.2

2.27

2.21

mmol/l

0.20

438

Maternal care related to the fetus and amniotic cavity and possible delivery problems

162

956

0.99

0.01

1.2

1.3

1.86

1.96

mmol/l

0.56

157

879

Delivery, wide proxy

114

610

0.99

0.01

1.5

1.2

2.06

1.99

mmol/l

0.35

106

554

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1.06

0.01

1.5

1.2

2.25

2.04

mmol/l

—

Other orthopaedic follow-up care

125

1.04

0.00

1.2

1.92

2.18

mmol/l

0.60

120

Congenital ovarian cysts

121

0.99

0.00

1.4

1.74

1.83

mmol/l

0.19

115

Ulcer of oesophagus

166

1.02

0.00

1.1

1.2

2.13

2.09

mmol/l

0.10

155

Benign neoplasm: Sigmoid colon

510

1.00

0.00

1.2

1.3

2.11

2.14

mmol/l

0.06

479

Other congenital malformations of the digestive system

139

1.00

0.00

1.4

1.3

1.67

1.82

mmol/l

0.60

133

Hypospadias with an incomplete glans penis

0.00

0.0

1.0

—

1.84

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.8

—

1.43

—

Paget disease

0.00

0.0

1.0

—

1.81

—

Cleft lip

0.00

0.0

1.6

—

1.60

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.0

—

1.65

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.4

—

1.41

—

Crushing injury of forearm

0.00

0.0

1.7

—

2.08

—

Chorioretinal scars

0.00

0.0

1.1

—

1.83

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.2

—

1.75

—

Malignant neoplasm of vagina, including Hilmo

0.00

0.0

1.1

—

2.00

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.4

—

1.42

—

Benign neoplasm: Hypopharynx

0.00

0.0

1.2

—

1.71

—

Other and unspecified parapsoriasis

0.00

0.0

1.3

—

1.77

—

Corneal pigmentations and deposits

0.00

0.0

1.4

—

1.76

—

Maxillary hypoplasia

0.00

0.0

1.4

—

1.49

—

Diphtheria

0.00

0.0

1.3

—

1.66

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.2

—

1.79

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

2.2

—

1.86

—

Isolated patent ductus arteriosus

0.00

-0.00

0.0

1.4

—

2.11

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.8

—

1.47

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

1.2

—

1.81

—

Unicornuate uterus

0.00

-0.00

0.0

1.6

—

1.94

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.3

—

1.74

—

Congenital malformations of lung

0.00

-0.00

0.0

1.8

—

1.52

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.0

—

1.98

—

Aortic stenosis

0.00

-0.00

0.0

1.0

—

1.49

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.0

—

1.47

—

Cleft lip and palate

0.00

-0.00

0.0

1.3

—

1.65

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.2

—

1.76

—

Epidermolysis bullosa

0.00

-0.00

0.0

1.4

—

1.44

—

0.00

-0.00

0.0

1.0

—

1.24

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.8

—

1.36

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.0

—

1.14

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

2.2

—

1.35

—

Birth injury to peripheral nervous system

0.00

-0.00

0.0

1.7

—

1.82

—

Premature separation of placenta [abruptio placentae]

0.95

-0.00

1.2

1.5

1.83

1.89

mmol/l

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.0

—

1.95

—

Hereditary lymphedema

0.00

-0.00

0.0

1.4

—

1.68

—

Cleft lip and cleft lip and palate

0.00

-0.00

0.0

1.3

—

1.65

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.2

—

1.65

—

Effects of air pressure and water pressure

0.00

-0.00

0.0

1.6

—

1.61

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.5

—

1.71

—

Membranous nephropathy

0.00

-0.00

0.0

1.1

—

1.72

—

Progressive systemic sclerosis

0.00

-0.00

0.0

1.0

—

1.92

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.4

—

1.96

—

Other rupture of muscle

0.00

-0.00

0.0

1.4

—

2.29

—

Injury of heart

0.00

-0.00

0.0

1.4

—

1.94

—

Lordosis

0.00

-0.00

0.0

1.4

—

1.67

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.2

—

1.55

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

1.89

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.2

—

1.93

—

Hypertrophy of bone

0.00

-0.00

0.0

1.5

—

1.67

—

Klinefelter syndrome, karyotype 47 XXY

0.00

-0.00

0.0

1.2

—

1.72

—

Foreign object accidentally left in body during surgical and medical care

0.00

-0.00

0.0

1.4

—

1.70

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.6

—

1.80

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

-0.00

0.0

1.6

—

2.10

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.0

—

1.61

—

Ulcer of oesophagus, drug-induced

0.00

-0.00

0.0

1.1

—

1.95

—

ILD medications: acetylcysteine

0.00

-0.00

0.0

1.1

—

2.14

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.0

—

1.52

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.2

—

1.61

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.4

—

1.72

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.7

—

1.45

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.2

—

1.75

—

Other specified disorders of external ear

0.96

-0.00

1.9

1.2

1.81

1.99

mmol/l

—

Hereditary factor VIII deficiency

0.00

-0.00

0.0

1.1

—

1.53

—

Complications specific to multiple gestation

0.00

-0.00

0.0

1.3

—

1.70

—

Myasthenia gravis, drug-induced

0.00

-0.00

0.0

1.0

—

1.73

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

1.3

—

1.77

—

Thyroid crisis or storm

0.00

-0.00

0.0

1.8

—

2.00

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

-0.00

0.0

1.3

—

1.79

—

Drug-induced gout

0.00

-0.00

0.0

1.0

—

1.97

—

Lipomatosis, not elsewhere classified

0.00

-0.00

0.0

1.8

—

1.76

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.0

—

1.66

—

Other or unspecified immunodeficiency

0.00

-0.00

0.0

1.3

—

1.94

—

Changes in corneal membranes

0.00

-0.00

0.0

1.0

—

1.71

—

Biliary cirrhosis, NAS

0.00

-0.00

0.0

1.2

—

1.87

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

-0.00

0.0

1.4

—

1.63

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.3

—

1.89

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.3

—

1.70

—

Urethral discharge

0.00

-0.00

0.0

1.5

—

1.85

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.6

—

2.01

—

Benign neoplasm: Lymph nodes

0.00

-0.00

0.0

1.4

—

1.70

—

Wilms' tumor, including Hilmo

0.00

-0.00

0.0

1.3

—

1.73

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.4

—

1.70

—

Femoral hernia

0.93

-0.00

1.2

2.69

2.03

mmol/l

—

Non-seminoma of testis

0.00

-0.00

0.0

1.3

—

1.55

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

1.81

—

General- and plastic-surgery devices associated with adverse incidents

0.00

-0.00

0.0

1.8

—

2.18

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

-0.00

0.0

1.4

—

1.68

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.2

—

2.03

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.2

—

1.77

—

Granulosa cell carcinoma of ovary

0.00

-0.00

0.0

1.2

—

1.79

—

Yaws

0.00

-0.00

0.0

1.3

—

1.71

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

1.3

—

1.91

—

Other operation for atrial fibrillation

0.00

-0.00

0.0

1.1

—

1.71

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.4

—

1.53

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

-0.00

0.0

1.3

—

2.12

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.8

—

2.02

—

Diphtheria

0.00

-0.00

0.0

1.3

—

1.66

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.6

—

1.86

—

Other haemoglobinopathies

0.00

-0.00

0.0

1.4

—

1.70

—

Ototoxic hearing loss

0.00

-0.00

0.0

1.0

—

1.76

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate [Moles/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS